---

RECTUM - Detailed Surgical Answers

---

Q1. Etiology and Recent Advances in Management of Prolapse Rectum ⭐⭐⭐

Etiology of Rectal Prolapse

• Laxity of rectal attachments to the sacrum
• Deep cul-de-sac (pouch of Douglas)
• Lack of fixation of rectum to the sacrum
• Large redundant sigmoid colon
• Weak pelvic floor and puborectalis muscle
• Connective tissue disorders (Marfan syndrome, Ehlers-Danlos syndrome - present at younger age)

• Females are 6 times more likely than males
• Peak incidence in the 7th decade
• Associated with multiparity, chronic straining, chronic constipation, neurological disorders (cauda equina, pudendal neuropathy), psychiatric illness

• 20-35% have urinary symptoms (anterior compartment prolapse)
• 15-30% have vaginal vault or uterine prolapse

1. Intussusception theory (Moschowitz, Broden & Snellman) - rectal prolapse is a sliding hernia through a fascial defect, beginning as internal intussusception at 6-8 cm from the anal verge
2. Pelvic floor laxity theory - redundant sigmoid colon descends through a widened levator hiatus

• Type I: Mucosal prolapse only (false prolapse)
• Type II: Full-thickness rectal prolapse (true prolapse) - concentric circumferential folds
• Type III: Internal intussusception (occult prolapse)

Recent Advances in Management

• MRI defecography: Can demonstrate cystocele, vaginal vault prolapse, enterocele, and internal intussusception - allows combined surgical planning
• High-resolution anorectal manometry: Evaluates sphincter function preoperatively
• Colonoscopy: Mandatory to exclude rectal mass as lead point before surgery

• Laparoscopic/Robotic Ventral Mesh Rectopexy (D'Hoore procedure): Currently the most popular minimal access approach - anterior mobilization only (preserves posterior nerves), mesh sutured to anterior rectum then to sacrum/promontory; lower recurrence, preserves continence, improves constipation
• STARR procedure (Stapled Trans-Anal Rectal Resection): For internal prolapse/obstructed defecation
• Robotic-assisted rectopexy: Better visibility in the pelvis, preservation of autonomic nerves
• Biological mesh: Used in younger patients to reduce mesh erosion risk
• Watch-and-wait strategies for asymptomatic internal intussusception

---

Q2 & Q10 (2018). Operative Steps of Laparoscopic Rectopexy / Various Surgical Methods for Prolapsed Rectum (20 marks) ⭐⭐⭐⭐

Surgical Methods - Overview

1. Transabdominal (preferred for fit patients) - lower recurrence (<10% at 10 years)
2. Perineal - for high surgical risk, elderly patients (recurrence 16-30%)

---

A. TRANSABDOMINAL APPROACHES

1. Posterior Suture Rectopexy (Wells/Ripstein Procedure)

1. Patient in Lloyd-Davies position, general anesthesia
2. Laparoscopic or open access, pneumoperitoneum
3. Peritoneum opened lateral to rectum on both sides
4. Rectum mobilized posteriorly down to the tip of the coccyx (full posterior mobilization)
5. Lateral ligaments preserved (dividing causes constipation)
6. Prolapse reduced
7. Rectum sutured (non-absorbable sutures) to the presacral fascia at S2-S3 level bilaterally
8. Peritoneum closed

2. Resection Rectopexy (Frykman-Goldberg)

• Posterior mobilization + rectopexy with sigmoid colectomy
• Indicated when significant sigmoid redundancy/constipation coexists
• Reduces constipation post-operatively

3. Ventral Mesh Rectopexy (D'Hoore Procedure) - CURRENT GOLD STANDARD

1. Laparoscopic access, patient in Trendelenburg
2. Peritoneum opened in the rectovaginal septum (between extraperitoneal rectum and vagina in females, Denonvilliers fascia in males)
3. Mobilization down to pelvic floor anteriorly only
4. Prolapse reduced into the abdomen
5. Permanent or biologic mesh sutured to anterior surface of the rectum
6. Mesh suspended and anchored to the sacral promontory (lateral view: mesh fixes rectum to sacrum; elevates pelvic floor)
7. Peritoneum closed over mesh

---

B. PERINEAL APPROACHES

4. Perineal Proctosigmoidectomy (Altemeier Procedure)

1. Spinal/local anesthesia; lithotomy position
2. Prolapsed bowel pulled out fully
3. Full-thickness circumferential incision 1-2 cm above the dentate line
4. Sigmoid mesentery ligated and divided adjacent to bowel wall
5. Redundant rectum and sigmoid excised
6. Levatoroplasty (posterior repair of levator ani) - reduces recurrence
7. Coloanal anastomosis completed (hand-sewn or stapled)

5. Delorme Procedure

1. Circumferential incision through mucosa 1 cm above dentate line
2. Mucosal sleeve stripped off the prolapsed bowel (mucosectomy)
3. Underlying muscularis plication with multiple absorbable sutures (imbrication)
4. Mucosal edges re-anastomosed

6. Thiersch Operation (Wire/Nylon Encirclement)

• Encirclement of the anus with a wire/nylon/silastic sling
• Historical procedure, largely abandoned
• High complication rate (fecal impaction, wire breaking, sepsis)
• Still occasionally used in very frail elderly

---

Comparison Table

---

Q2 (2016). Procedure for Rectopexy ⭐⭐⭐

---

Q3. Describe Treatment and Management of Carcinoma Rectum ⭐⭐⭐⭐

Staging (TNM)

• T1: Submucosa | T2: Muscularis propria | T3: Perirectal fat | T4: Adjacent organs/visceral peritoneum
• N0-N2: Nodal status | M0/M1: Distant metastasis

Neoadjuvant Therapy (Pre-operative)

• Long-course chemoradiotherapy (CRT): 50.4 Gy in 28 fractions with concurrent infusional 5-FU; surgery 6-8 weeks after completion (allows maximal downstaging)
• Short-course radiotherapy: 25 Gy in 5 fractions; surgery within 1 week
• Total Neoadjuvant Therapy (TNT): Chemotherapy + CRT before surgery; increasing use to maximize chance of complete response and address micrometastases early

• Neoadjuvant vs. adjuvant CRT: improved local recurrence (7% vs. 10%), better compliance (90% vs. 50%), reduced grade ≥3 toxicity, better sphincter preservation (39% vs. 19%)
• No significant OS difference

Surgical Management

• Surgery is the mainstay of curative therapy
• Primary resection by Total Mesorectal Excision (TME)
• Early cancers (T1, selected T2): Local excision (TEMS/TEM)
• Most cases: Anterior resection with colorectal or coloanal anastomosis using circular stapling device
• Low extensive tumors: Abdominoperineal excision (APE) with permanent colostomy

Anterior Resection (AR)

• For tumors of upper and mid-rectum
• TME dissection
• Circular stapler used for anastomosis (double-stapling technique)
• Defunctioning loop ileostomy for low anastomoses

Low Anterior Resection (LAR)

• For lower rectal tumors, with at least 1-2 cm distal margin
• Coloanal anastomosis or colopouch-anal anastomosis (J-pouch improves functional outcomes)

Abdominoperineal Excision (APE / Miles' Operation)

• For tumors < 2-3 cm from anal verge where sphincter preservation impossible
• Permanent end colostomy
• Extralevator APE (ELAPE): More radical en-bloc resection - reduces circumferential resection margin (CRM) positivity

Adjuvant Therapy (Post-operative)

• For patients not given neoadjuvant therapy or for high-risk T3/N+ disease
• 5-FU or capecitabine-based chemotherapy
• Post-op RT if margins positive

Local Recurrence Rates (without TME)

• T1-T2: Up to 10%
• T3N0: 15-35%
• T3-T4 N+: 45-65%
• With TME + neoadjuvant CRT: Reduced to 5-8%

---

Q4. Case of Painless Bleeding Per Rectum (PR) in 45-Year-Old Patient ⭐⭐⭐

Approach to Painless PR Bleeding

Differential Diagnosis (Causes of Painless Rectal Bleeding)

1. Haemorrhoids (Internal) - most common; bright red blood, separate from stool, on paper/pan
2. Colorectal carcinoma - blood mixed with stool, altered bowel habit, weight loss
3. Colonic diverticulosis - most common cause of acute severe LGI bleeding; painless, large-volume
4. Colonic polyps/adenoma - 20% of LGI bleeding
5. Angiodysplasia/vascular malformations - painless, elderly
6. Inflammatory bowel disease - usually with mucus, urgency
7. Colitis (ischaemic, infective) - may be painless
8. Rectal prolapse - mucus and blood

History Taking

• Duration, frequency, volume of bleeding
• Color: Bright red (anorectal/left colon) vs. dark/maroon (right colon)
• Relation to stool: Separate (haemorrhoids) vs. mixed (carcinoma)
• Associated symptoms: Weight loss, altered bowel habit, tenesmus, mucus
• Family history of CRC/polyps
• Drug history: NSAIDs, anticoagulants

Investigations

• Full blood count (anaemia)
• Proctoscopy/sigmoidoscopy: To see internal haemorrhoids, rectal polyps, low rectal carcinoma
• Colonoscopy (urgent): Investigation of choice in 45-year-old - visualizes entire colon, biopsy, therapeutic

• CT colonography
• Nuclear medicine scan (Tc-99m RBC scan) if brisk bleeding (detects 0.1 mL/min)
• CT mesenteric angiography (detects 0.5-1 mL/min)
• Capsule endoscopy (small bowel source)

Management

• Haemorrhoids: Conservative, injection sclerotherapy, rubber band ligation, haemorrhoidectomy
• Colorectal carcinoma: Staging then surgical resection +/- chemoradiotherapy
• Diverticular bleeding: 80% settle spontaneously; colonoscopic hemostasis, angioembolization, or surgery
• Angiodysplasia: Colonoscopic argon plasma coagulation

---

Q5. Anatomy of Ischiorectal Fossa and Its Surgical Significance ⭐⭐⭐

Anatomy

1. Fat body of the ischioanal fossa - fills the space; allows distension of the anal canal during defecation
2. Inferior rectal (haemorrhoidal) vessels and nerve - cross the fossa transversely to reach the anal canal
3. Pudendal canal (Alcock's canal) - a fascial sheath on the lateral wall within obturator fascia containing:
   • Internal pudendal artery and vein
   • Pudendal nerve (S2, S3, S4)
4. Perineal branches of S3, S4 nerve
5. Posterior labial/scrotal nerves

Surgical Significance

1. Ischiorectal (ischioanal) abscess: The fat-filled space is the site of ischiorectal abscess. Pus can spread:
   • Posteriorly to form horseshoe abscess (communicates to the opposite side through post-anal space)
   • Upward to form supralevator abscess
   • Treatment: Incision and drainage with liberal opening of the abscess cavity
2. Fistula-in-ano: Ischiorectal abscess can result in high anal fistula (suprasphincteric or extrasphincteric). Seton placement is used for complex high fistulas.
3. Pudendal nerve block: The pudendal nerve lies in Alcock's canal on the lateral wall - accessible for nerve block (trans-perineal or trans-vaginal approach to ischial spine) for anorectal operations.
4. Cancer surgery: During APE (Abdominoperineal Excision) and ELAPE, the fossa is dissected to achieve adequate margins. In ELAPE, the levator muscles are divided at their origin to get a wider specimen and avoid "coning."
5. Fossa used for drainage routes: Drainage of pelvic/perirectal abscesses is often performed through the ischiorectal fossa (posterior approach).
6. Rectal prolapse surgery: Perineal nerve injury within the fossa can contribute to pudendal neuropathy causing incontinence.

---

Q6. Surgical Technique of Total Mesorectal Excision (TME) ⭐⭐⭐⭐

Concept and Rationale

• Mesorectum contains lymph nodes, lymphatics, blood vessels, and potentially cancer deposits up to 5 cm distal to the tumor
• Incomplete TME ("coning") leaves mesorectal tissue with potential cancer - causes local recurrence
• TME achieves circumferential resection margin (CRM) negativity - the single most important predictor of local recurrence

Preoperative Preparation

• High-resolution MRI pelvis: Defines mesorectal fascia, CRM, tumor extent, node status
• Neoadjuvant CRT if T3/T4 or N+
• Bowel preparation, prophylactic antibiotics
• Counseling for stoma

Operative Steps

• Midline laparotomy or laparoscopic ports
• Thorough exploration to exclude metastases

• Identify left ureter (must be protected)
• Divide sigmoid mesentery at the origin of the inferior mesenteric artery (IMA) - high ligation for lymph node yield

• Incise the peritoneum on each side of the rectum
• Develop the pre-sacral (retrorectal) space between the mesorectal fascia and the parietal endopelvic fascia - this is the avascular "holy plane" (appears as shiny, white, areolar tissue)
• Dissection proceeds posteriorly under direct vision - avoid "coning" onto the mesorectum

• Lateral ligaments divided (if doing full TME) - contains autonomic nerves medially
• Hypogastric nerve preservation: Pelvic autonomic plexus (inferior hypogastric plexus, T10-L1 sympathetic, S2-S4 parasympathetic) lies just outside the mesorectal plane - preserved by sharp dissection in the correct plane

• Denonvilliers fascia separates the rectum from the prostate/seminal vesicles (males) or vagina (females)
• Dissection anterior to Denonvilliers fascia preserves it on the prostate/vagina

• Dissection continued to the anorectal junction (tip of coccyx posteriorly, levator ani plane)
• For TME: Complete mobilization to the pelvic floor
• Maintain at least 1-2 cm distal margin below the tumor

• Rectum transected with a linear stapler
• Specimen examined: Mesorectum should be intact (smooth surface, no coning, no tears)
• Anastomosis with circular stapler (double-stapling technique) for anterior resection
• Defunctioning loop ileostomy for low anastomoses (leak risk)
• Or permanent end colostomy for APE

Autonomic Nerve Preservation

• Sympathetic: Hypogastric nerves (L1) - responsible for ejaculation and bladder neck closure
• Parasympathetic: Nervi erigentes (S2-4) - responsible for erection
• Combined injury: Impotence, bladder dysfunction

Specimen Assessment (Quality Control)

• Complete mesorectum: Smooth surface, intact, no defects > 5 mm
• Nearly complete: Moderate bulk, some irregularity
• Incomplete: Little mesorectum, coning defect

---

Q7. Recent Controversies Related to Carcinoma Rectum ⭐⭐⭐

1. Watch and Wait (W&W) vs. Surgery After Complete Clinical Response

• After neoadjuvant CRT, approximately 20% achieve complete clinical response (cCR)
• W&W strategy avoids unnecessary surgery with its morbidity (impotence, incontinence, stoma)
• Controversy: 25-30% of cCR patients have residual viable tumor on histology; risk of distant metastasis remains
• Requires very close surveillance: MRI, endoscopy, CEA every 3 months for 2 years

2. Total Neoadjuvant Therapy (TNT) vs. Standard CRT + Surgery

• TNT: All chemotherapy given pre-operatively (FOLFOX/CAPOX + CRT or CRT + FOLFOX)
• RAPIDO trial (2021) and PRODIGE 23 trial: TNT improves pCR rates and reduces distant metastases
• Controversy: Does this improve OS? Does it increase surgical morbidity by over-treating?

3. Local Excision for T2 Rectal Cancer

• TEM/TEMS (Transanal Endoscopic Microsurgery) for T1 tumors: well-established
• For T2: High local recurrence with local excision alone (15-20%) - requires adjuvant CRT
• Controversy: Can TEM + CRT replace radical resection for selected T2?

4. Lateral Pelvic Node Dissection (LPND)

• East-West controversy: Japan routinely performs extended lateral lymph node dissection
• Western approach: TME + neoadjuvant CRT controls lateral nodes without LPND
• Controversy: Does LPND benefit patients with cN+ lateral nodes despite CRT?

5. Robotic vs. Laparoscopic TME

• COLOR II, ACOSOG Z6051, ALaCaRT trials: Laparoscopic vs. open TME - non-inferiority not consistently demonstrated
• Robotic: Better visualization of the deep pelvis, potentially lower conversion rates
• Controversy: Is robotic TME superior to laparoscopic? Cost-effectiveness?

6. Definition of Adequate Distal Margin

• Previously 5 cm distal margin required (Miles' era)
• Now: 1-2 cm accepted for sphincter preservation, especially after neoadjuvant downstaging
• Controversy: Is 1 cm truly adequate for T3/T4 tumors?

7. Defunctioning Stoma After LAR

• Should all low anastomoses be defunctioned? Mandatory or selective?
• Routine defunctioning reduces symptomatic anastomotic leak but stoma reversal has its own complications

---

Q8. Stapler Haemorrhoidectomy (PPH - Procedure for Prolapse and Haemorrhoids) ⭐⭐⭐

Principle

1. Excise a ring of prolapsed anorectal mucosa above the dentate line
2. Restore the haemorrhoidal cushions to their normal anatomical position
3. Interrupts blood supply to the haemorrhoids (devascularization)

Indications

• 3rd and 4th degree internal haemorrhoids (prolapsing)
• Circumferential haemorrhoidal disease
• Mucosal/internal prolapse

Operative Steps

1. Position: Lithotomy or prone jack-knife; general/spinal anaesthesia
2. Insertion of circular anal dilator (CAD): Purse-string suture applicator used
3. Purse-string suture: Placed at 3-4 cm above the dentate line (in the rectal mucosa above the haemorrhoids) using the purse-string anoscope
4. Circular stapler inserted: Opened to maximum, then introduced through CAD
5. Purse-string tied around the shaft of the open stapler
6. Stapler closed and fired: Excises a doughnut of mucosa and submucosa (2-3 cm wide), and forms a stapled anastomosis; haemorrhoidal cushions pulled up and devascularized
7. Specimen checked: The doughnut of tissue inspected to confirm completeness (must contain mucosa circumferentially)
8. Hemostasis: Check anastomotic line for bleeding, suture if needed

Advantages (Merits)

• Less postoperative pain (excision above dentate line avoids somatic nerve pain)
• Faster return to work and normal activities
• Shorter operating time
• Better short-term patient satisfaction
• Less anal stenosis

Disadvantages (Demerits)

• Higher long-term recurrence rate compared to conventional haemorrhoidectomy
• Risk of rectovaginal fistula (if posterior vaginal wall included in purse-string)
• Staple-line dehiscence and bleeding
• Rectal stricture (if too much tissue excised)
• Pelvic sepsis (rare but life-threatening)
• STARR complications: Urgency, defecatory dysfunction

---

Q9. Merits and Demerits of Various Procedures for Treatment of Haemorrhoids ⭐⭐⭐

1. Conservative Management

---

2. Injection Sclerotherapy

---

3. Rubber Band Ligation (Barron's Banding)

---

4. Milligan-Morgan Haemorrhoidectomy (Open)

---

5. Stapled Haemorrhoidopexy (PPH/Longo's)

---

6. HAL-RAR (Haemorrhoidal Artery Ligation - Recto Anal Repair)

---

7. Infrared Coagulation / Cryotherapy

---

Summary Recommendation (Degree-Based)

---

Q10 (Mechanism). Mechanism of Rectal Prolapse and Principles Involved in Various Operative Procedures ⭐⭐⭐

Mechanism of Rectal Prolapse

• Rectal prolapse begins as a circumferential full-thickness intussusception of the anterior rectal wall at 6-8 cm from the anal verge
• A deep pouch of Douglas (cul-de-sac) with weakened peritoneal supports allows the anterior rectal wall to herniate
• Repeated intussusception deepens the prolapse until it becomes complete, protrudes through the anus
• Supports this: Cine-defecography shows intussusception 6-8 cm above the dentate line as the initiation point

• Primary defect is in the pelvic floor musculature (weakened levator ani, puborectalis)
• Redundant sigmoid colon descends through the widened levator hiatus
• Rectal fixation to the sacrum is lost (no normal lateral ligaments)
• Diastasis of the levator ani creates a wide hiatus

• Deep rectovesical/rectouterine pouch
• Diastasis of levators
• Lax and patulous anal sphincter
• Loss of normal sacral curvature of rectum (rectum hangs straight)
• Redundant sigmoid

Principles Behind Various Operations

1. Fix the rectum to a stable structure (sacrum, presacral fascia)
2. Obliterate the deep cul-de-sac (prevent anterior herniation)
3. Remove redundant bowel (reduce telescoping)
4. Repair pelvic floor (levatoroplasty in perineal operations)
5. Restore anal sphincter tone (damaged sphincter may need separate repair)

---

Key References:

• Bailey and Love's Short Practice of Surgery, 28th Edition
• Sabiston Textbook of Surgery - The Biological Basis of Modern Surgical Practice
• Current Surgical Therapy, 14th Edition
• Fischer's Mastery of Surgery, 8th Edition
• Sleisenger and Fordtran's Gastrointestinal and Liver Disease
• Color Atlas of Human Anatomy, Vol 2All 10 questions answered in detail. Here's a quick orientation guide to help you use these answers for exams:

---

Quick Guide to Exam Weightage

• TME technique is the single most exam-important surgical procedure for rectum topics
• Rectal prolapse operations (especially Altemeier and Ventral Mesh Rectopexy) are heavily tested
• The German Rectal Study data for neoadjuvant vs adjuvant CRT is a classic exam fact
• For haemorrhoids: The degree-based treatment ladder should be memorized
• Ischiorectal fossa: Focus on Alcock's canal contents and horseshoe abscess pathway for surgical significance

---

Exam Weightage Guide

---

Q1. Peptic Ulcer Disease ⭐⭐⭐⭐

Definition

Epidemiology

• Global incidence declining due to better understanding of H. pylori and NSAID risks
• The Global Burden of Disease study shows a 31% decrease in PUD incidence/prevalence from 1990-2019
• Hospitalization and mortality rates also declining
• Need for surgery greatly decreased with medical eradication therapy

Pathogenesis - Balance of Protective vs. Aggressive Factors

• Mucosal bicarbonate secretion
• Mucus production (mucus-bicarbonate barrier)
• Adequate mucosal blood flow
• Growth factors (EGF, TGF-alpha)
• Cell renewal and regeneration
• Endogenous prostaglandins (PGE2, PGI2)

• Hydrochloric acid secretion
• Pepsin
• H. pylori infection (most important)
• NSAIDs/aspirin
• Ethanol ingestion
• Smoking
• Duodenal reflux of bile
• Ischemia, hypoxia
• Zollinger-Ellison Syndrome (gastrinoma)

Causes of PUD

1. H. pylori infection - associated with 90% of duodenal ulcers and 70-90% of gastric ulcers
2. NSAIDs - inhibit COX-1 and COX-2, reduce prostaglandin synthesis, impair mucosal protection
3. Zollinger-Ellison Syndrome - gastrin-secreting tumor causing hypersecretion
4. Stress ulcers - Cushing's ulcer (head injury), Curling's ulcer (burns)
5. Others: steroids, smoking, rare infections

Differences: Gastric vs. Duodenal Ulcer

Complications

1. Bleeding - most common complication; hematemesis/melena; manage with endoscopy (injection, clips, heater probe), angioembolization, surgery
2. Perforation - second most common; sudden severe epigastric pain, rigidity; air under diaphragm on erect CXR; emergency surgery (Graham patch)
3. Gastric outlet obstruction - chronic scarring; projectile vomiting, succussion splash; hypokalemic hypochloremic metabolic alkalosis
4. Malignant change - gastric ulcer only; biopsy all gastric ulcers

---

Q2 / Q1(2018). Pharmacological Basis of Medical Treatment of Acid Peptic Disease ⭐⭐⭐⭐⭐

Classification of Drugs

1. Antacids

• Aluminum hydroxide: Slow-acting, causes constipation
• Magnesium hydroxide: Faster-acting, causes diarrhea
• Calcium carbonate: Fast-acting, risk of acid rebound
• Combination preparations (Maalox, Gelusil): Balance side effects

---

2. H2 Receptor Antagonists (H2RAs)

• Famotidine (most potent)
• Ranitidine (withdrawn in many countries due to NDMA)
• Nizatidine
• Cimetidine (weakest; also inhibits CYP450 - drug interactions)

---

3. Proton Pump Inhibitors (PPIs) - MAINSTAY OF TREATMENT

• Prodrugs activated in the acidic canalicular environment of the parietal cell
• Irreversibly inhibit the H⁺/K⁺ ATPase (proton pump) - the final common pathway of acid secretion
• Block acid secretion stimulated by histamine, gastrin, and acetylcholine (all three pathways blocked, unlike H2RAs which only block histamine pathway)
• New pump synthesis required to restore acid secretion (takes ~3-5 days for full acid suppression recovery)

• GERD
• PUD (gastric and duodenal ulcers)
• H. pylori eradication (component of triple/quadruple therapy)
• Zollinger-Ellison Syndrome (high dose)
• NSAID-associated ulcer prevention
• Stress ulcer prophylaxis in ICU

• Hypomagnesemia
• Vitamin B12 deficiency (reduced intrinsic factor function)
• C. difficile infection risk
• Osteoporosis/fracture risk (impaired calcium absorption)
• Rebound acid hypersecretion on discontinuation

---

4. Mucosal Protective Agents (Cytoprotectives)

• Complex of aluminum hydroxide and sulfated sucrose
• In acidic pH, polymerizes to form a paste-like protective coating that adheres to ulcer base
• Binds to proteins in the ulcer crater
• Stimulates prostaglandin synthesis and mucus secretion
• Also binds pepsin and bile salts

• Synthetic PGE1 analogue
• Stimulates mucus and bicarbonate secretion
• Increases mucosal blood flow
• Inhibits acid secretion (via EP3 receptors on parietal cells)
• Used specifically for NSAID-induced ulcer prevention
• Side effects: Diarrhea, abdominal cramps, uterine contractions (contraindicated in pregnancy)

• Coat ulcer base, stimulate mucus secretion
• Direct antibacterial activity against H. pylori
• Inhibit bacterial urease
• Used as 4th component of bismuth quadruple therapy

---

5. Helicobacter pylori Eradication Regimens

• PPI (standard dose BD) + Clarithromycin 500 mg BD + Amoxicillin 1g BD
• If penicillin allergy: replace amoxicillin with Metronidazole 400 mg BD

• PPI + Bismuth subcitrate + Tetracycline 500 mg QID + Metronidazole 400 mg TID

• Prior macrolide antibiotic exposure
• Local clarithromycin resistance >15%
• Penicillin allergy + recent metronidazole use
• Failed standard triple therapy

• Urea breath test (UBT) or stool antigen test 4-6 weeks after completing therapy
• Endoscopy with biopsy if re-ulceration suspected

• Successful eradication: Recurrence rates fall to 2% (vs. 80% without eradication)
• ~20-30% of patients fail initial therapy (antibiotic resistance)

---

6. Anticholinergic Drugs

• Pirenzepine (M1 selective) - reduces acid by blocking vagal stimulation
• Now rarely used due to side effects (dry mouth, urinary retention, blurred vision)

7. H2 Antagonist Note: Combined PPIs + Antacids/H2RAs

• Generally not recommended together - promoting alkaline environment may have deleterious effects
• Maintenance PPI therapy reserved for: Large ulcers (>2 cm), refractory/frequent PUD, failed H. pylori eradication, patients requiring continued NSAIDs/aspirin

---

Q3. Etiology, Clinical Features & Management of H. pylori Infection (2017) ⭐⭐⭐⭐

Microbiology

Virulence Factors

• Urease production (most important): Splits urea → ammonia + bicarbonate → creates alkaline microenvironment; protects bacteria from gastric acid
• Flagella: Motility through mucus layer
• Mucolytic enzymes: Passage through mucus; protection from mucin's antibiotic effects
• Surface adhesins: Attachment to gastric epithelial cells
• CagA gene (cytotoxin-associated gene A): Oncogenic protein; associated with higher risk of gastric cancer and more severe gastritis
• VacA gene (vacuolating cytotoxin): Causes epithelial vacuolation and mucosal damage

Epidemiology

• Affects two-thirds of the world's population; prevalence ~43% globally (down from 58% in 1980s)
• Higher prevalence in developing countries (>80% in some)
• ~80% of infected individuals are asymptomatic
• Fecal-oral and oral-oral transmission; associated with poor sanitation

Disease Associations

• 15-20% lifetime risk of PUD
• 90% of duodenal ulcers and 70-90% of gastric ulcers
• 70% of gastric cancers linked to H. pylori infection
• Most primary gastric MALT lymphomas
• WHO: H. pylori classified as a Class I carcinogen

Mechanisms of Mucosal Injury

1. Direct epithelial damage by CagA/VacA toxins
2. Urease produces ammonia → toxic to epithelium
3. Induces inflammatory response (TNF-α, IL-1, IL-6, IL-8) → gastritis
4. Increases gastrin secretion → hypersecretion of acid
5. Decreases somatostatin → removes inhibitory control of acid
6. Disrupts mucus gel layer → impairs mucosal defense

Pathology

• Microscopically: Prominent lymphoplasmacytic infiltrate in lamina propria + neutrophils (active gastritis)
• Lymphoid follicles with germinal centers in nearly all infected patients
• Long-standing infection → intestinal metaplasia → dysplasia → adenocarcinoma (Correa cascade)

Diagnosis

1. CLO (Campylobacter-like organism) test / Rapid urease test - most practical; biopsy from antrum; high sensitivity and specificity
2. Histology (gold standard) - H&E + Giemsa or Warthin-Starry silver stain
3. Bacterial culture - most specific; allows sensitivity testing; difficult, slow
4. Molecular tests (PCR) - detect antibiotic resistance genes

1. Urea Breath Test (UBT) - most accurate non-invasive test; C13 or C14 labelled urea; 95% sensitivity and specificity; test of cure preferred method
2. Stool antigen test (SAT) - monoclonal antibody test; good for diagnosis and test of cure
3. Serology (IgG) - poor specificity; cannot distinguish active from past infection; NOT used for test of cure

Management (see Q2 for full pharmacology)

• Eradication reduces recurrence from 80% to 2%
• Triple therapy (PPI + Clarithromycin + Amoxicillin) 14 days
• Bismuth quadruple therapy if resistance risk
• Test of cure: UBT or SAT at 4-6 weeks

---

Q4/Q5. Etiology, Clinical Features & Management of Gastric Outlet Obstruction (GOO) (2014/2023) ⭐⭐⭐⭐⭐

Etiology

1. Peptic ulcer disease (duodenal ulcer / pyloric channel ulcer - most common benign cause)
   • Mechanism: Acute - mucosal edema around active ulcer; Chronic - fibrous scarring and stenosis
2. Pyloric stenosis (adult hypertrophic)
3. Crohn's disease involving the duodenum
4. Caustic ingestion (acid/alkali)
5. Post-surgical stricture (anastomotic)
6. Bezoar at the pyloric area
7. Pancreatic pseudocyst extrinsic compression
8. Gallstone obstruction (Bouveret syndrome)

1. Gastric carcinoma (antrum/pylorus) - most common malignant cause
2. Pancreatic carcinoma
3. Duodenal carcinoma
4. Lymphoma
5. Metastatic disease (extrinsic compression)

Key point from Bailey & Love: "With the decreasing incidence of peptic ulceration, gastric outlet obstruction should be considered malignant until proven otherwise."

Metabolic Consequences (Classic Exam Question!)

1. Vomiting of HCl → loss of H⁺ and Cl⁻ → primary hypochloremic alkalosis
2. Volume depletion → kidneys retain Na⁺ (aldosterone activated)
3. To retain Na⁺, kidneys exchange K⁺ and H⁺ → hypokalemia
4. Paradoxically acidic urine (despite systemic alkalosis) - because kidneys excrete H⁺ to conserve Na⁺/K⁺
5. Alkalosis → decreased ionized calcium → tetany
6. Progressive: Hyponatremia, hypokalemia, dehydration

Clinical Features

• Long history of peptic ulcer disease (benign) or short history with weight loss (malignant)
• Nausea and non-bilious vomiting (hallmark - bile-free because obstruction above ampulla of Vater)
• Vomit: Undigested food, foul-smelling, no bile
• Epigastric distension, early satiety
• Significant weight loss
• Dehydration

• Visible gastric peristalsis (left to right in thin patients)
• Succussion splash (audible or palpable - 4-6 hours after a meal or on first examination)
• Dehydration signs (dry tongue, sunken eyes, reduced skin turgor)
• Epigastric fullness/mass (malignant)

Investigations

1. Bloods: U&E (hypokalemia, hyponatremia), ABG (metabolic alkalosis), low Cl⁻, FBC (anaemia)
2. Urine: Low chloride, initially high bicarbonate; later paradoxically acidic urine
3. Upper GI Endoscopy + Biopsy - essential to visualize, assess degree of stenosis, biopsy to exclude malignancy
4. Barium meal/swallow - shows dilated stomach, delayed gastric emptying, point of obstruction
5. CT abdomen with contrast - staging if malignancy suspected; shows extent, nodes, metastases

Management

Step 1: Resuscitation and Correction of Metabolic Abnormalities (MANDATORY first)

• IV Isotonic Normal Saline (0.9% NaCl) - replaces sodium, chloride, and water; allows kidneys to correct alkalosis
• IV Potassium chloride (KCl) - correct hypokalemia (often requires 40-60 mmol/day or more)
• Wide-bore nasogastric tube - decompress and lavage stomach until clear returns
• Monitor urine output, U&E daily until correction
• Tetany: IV calcium gluconate

Step 2: Nutritional Support

• TPN or nasojejunal feeding if nutrition severely compromised

Step 3: Specific Treatment

• Aggressive medical therapy: PPI + H. pylori eradication → ~50% of early cases resolve with edema reduction
• Endoscopic balloon dilatation: Most useful for benign strictures; may need multiple sessions; 50% avoid surgery for 1-2 years
• Surgery (required for refractory/recurrent benign GOO):
  • Vagotomy + Antrectomy (V/A): Gold standard; lowest recurrence; 2% mortality
  • Vagotomy + Gastrojejunostomy (V/GJ): Good alternative; lower mortality; laparoscopically feasible; GJ can be reversed
  • Billroth II (antecolic isoperistaltic gastrojejunostomy): Common reconstruction after antrectomy
  • Pyloroplasty alone (Heineke-Mikulicz) - rarely used for tight pyloric stenosis

• Surgical resection if curative intent (D1/D2 gastrectomy)
• Duodenal stent (self-expanding metallic stent, SEMS): For unresectable malignancy; rapid symptomatic relief; allows oral feeding; palliative
• Palliative gastrojejunostomy: Surgical bypass; more durable but higher morbidity than stenting
• Chemotherapy + targeted therapy for metastatic disease

---

Q6 & Q7. Post-Gastrectomy Complications / Complications of Billroth II Gastrectomy ⭐⭐⭐⭐⭐

Overview of Gastrectomy Types

• Billroth I (BI): Gastroduodenostomy - gastric remnant anastomosed directly to duodenum
• Billroth II (BII): Gastrojejunostomy - gastric remnant anastomosed to jejunal loop (more complications)
• Roux-en-Y: Gastric remnant to Roux limb of jejunum (gold standard in modern surgery)

---

POST-GASTRECTOMY SYNDROMES (Full Classification)

A. METABOLIC COMPLICATIONS

• Loss of parietal cells → reduced acid secretion → impaired iron absorption (iron best absorbed as Fe²⁺ in acid environment)
• Also reduced intrinsic factor → B12 deficiency (megaloblastic anaemia)
• Management: Oral iron, IM B12 injections

• Reduced calcium absorption (calcium requires acid for solubilization in duodenum)
• Exclusion of duodenum (BII) reduces calcium absorption
• Management: Calcium + Vitamin D supplementation

• Reduced stomach size (small reservoir)
• Rapid transit
• Bacterial overgrowth in blind loop (BII)

---

B. MECHANICAL COMPLICATIONS

• Mechanism: Rapid transit of hyperosmolar food into jejunum → fluid shift from intravascular space into bowel lumen → hypovolemia; also release of VIP, serotonin, bradykinin
• Symptoms: Explosive diarrhea, bloating, nausea, vomiting, sweating, palpitations, flushing, dizziness, hypotension
• Management:
  • Dietary: Small frequent meals; avoid liquids with meals; high protein-fat, low simple carbohydrate diet; lie down after meals
  • Pharmacological: Octreotide (somatostatin analogue) - reduces intestinal transit and hormonal release; most effective medical therapy
  • Surgical: Conversion to Roux-en-Y (for severe refractory cases)

• Mechanism: Rapid glucose absorption → hyperglycemia → excessive insulin release → rebound hypoglycemia
• Symptoms: Hunger, sweating, weakness, tremors, confusion (hypoglycemic symptoms)
• Management: Small meals, complex carbohydrates, Acarbose (delays glucose absorption)

---

• Mechanism: Afferent limb (carrying bile/pancreatic secretions) becomes kinked, twisted, or too long → bile and pancreatic juice accumulate in the loop → intermittent obstruction
• Acute afferent loop syndrome: Surgical emergency; complete obstruction of afferent loop; distension, bilious vomiting delayed (loop full before overflow), RUQ pain; risk of duodenal blow-out
• Chronic afferent loop syndrome: Intermittent; postprandial RUQ pain/fullness relieved by sudden bilious vomiting (not containing food); malabsorption, bacterial overgrowth in loop
• Management: Conversion to Roux-en-Y

---

• Mechanical obstruction of efferent limb at anastomosis (adhesions, herniation through mesenteric defect, intussusception)
• Bile-stained vomiting, obstruction symptoms
• Management: Reoperation

---

• Mechanism: Bile and pancreatic secretions reflux through anastomosis into gastric remnant → chemical gastritis
• Symptoms: Constant burning epigastric pain NOT relieved by food, bile-stained vomiting, weight loss
• Distinction from marginal ulcer: Pain not relieved by food/antacids; bile in vomitus
• Investigations: Endoscopy (erythematous gastric mucosa, bile pooling), Tc-HIDA scan (bile reflux)
• Management: Cholestyramine, Sucralfate, Antacids; Surgery (Roux-en-Y conversion) for refractory cases

---

• Problem with Roux-en-Y reconstruction
• Roux limb loses normal propagating contractions → delayed gastric emptying
• Symptoms: Nausea, vomiting, abdominal pain, delayed transit
• Management: Prokinetics (Metoclopramide, Domperidone, Erythromycin); occasionally re-operation

---

• 20-30% incidence after truncal vagotomy
• Mechanism: Loss of vagal tone → altered gastric motility, rapid gastric emptying; altered bile salt metabolism
• Episodic explosive watery diarrhea (often postprandial)
• Management: Dietary, Cholestyramine, Loperamide; rarely reversed gastric tube interposition to slow transit

---

• After vagotomy (removes tonic contraction of antrum)
• Gastroparesis symptoms: Nausea, bloating, vomiting
• Management: Prokinetics; Enteral feeding via jejunostomy; rarely completion gastrectomy

---

• Ulcer at the anastomosis (usually on jejunal side)
• Due to: Inadequate acid reduction (incomplete vagotomy), Retained antrum (failed to excise all gastrin-producing antral mucosa)
• Symptoms: Epigastric pain, bleeding, perforation
• Investigation: Endoscopy, serum gastrin (if ZES suspected)
• Management: PPI (high dose); H. pylori eradication; revision surgery

---

• Risk increased 3-5x after 15-20 years post-gastrectomy (BII > BI)
• Mechanism: Bile reflux gastritis → intestinal metaplasia → dysplasia → carcinoma; chronic atrophic gastritis
• Surveillance endoscopy recommended

---

• Temporary dysphagia from esophageal spasm/denervation after vagotomy
• Usually resolves spontaneously

---

• Particularly after BII: Exclusion of duodenum from food stream → impaired mixing of bile/pancreatic juice with food; bacterial overgrowth in afferent loop consuming B12 and fat-soluble vitamins

---

Summary Table: Billroth II Specific vs. General Post-Gastrectomy Complications

---

Q8. Etiology, Clinical Features & Management of Pre-pyloric Ca Stomach ⭐⭐⭐⭐

Classification of Gastric Carcinoma

• Intestinal type (Lauren classification) - glandular structures; related to H. pylori, dietary factors, intestinal metaplasia; more common in older males; better prognosis
• Diffuse type - poorly cohesive cells; signet ring cells; CDH1 (E-cadherin) mutation; more common in young, females; worse prognosis; linitis plastica pattern
• Mixed type

Etiology/Risk Factors

1. H. pylori infection (most important - WHO Class I carcinogen)
2. Diet: High salt, nitrates, smoked/preserved foods; low Vitamin C
3. Smoking (doubles risk)
4. Alcohol
5. Obesity (gastroesophageal junction tumors)

1. Atrophic gastritis (with intestinal metaplasia)
2. Pernicious anaemia (3x risk)
3. Post-gastrectomy remnant (15-20 years)
4. Gastric polyps (adenomatous)
5. Menetrier's disease (hypertrophic gastropathy)

1. H. pylori CagA-positive strains
2. CDH1 (E-cadherin) germline mutation - hereditary diffuse gastric cancer
3. Lynch syndrome
4. Familial adenomatous polyposis (FAP)
5. Blood group A (increased risk)
6. First-degree relatives with gastric cancer

Staging (TNM/AJCC 8th Edition)

• T1: Lamina propria/submucosa (T1a: LP; T1b: SM)
• T2: Muscularis propria
• T3: Subserosa
• T4a: Serosa; T4b: Adjacent organs
• N1-3: Regional nodes
• M1: Distant metastasis

• Early Gastric Cancer (EGC): T1 (mucosa/submucosa) - excellent prognosis >90% 5-year survival
• Advanced: T2-T4

Clinical Features (Pre-pyloric)

• Dyspepsia, epigastric discomfort
• Anorexia, early satiety
• Vague abdominal pain

• Symptoms of GOO: Nausea, non-bilious vomiting, weight loss (as pre-pyloric location obstructs outflow)
• Dysphagia (proximal tumors)
• Haematemesis/melena
• Palpable epigastric mass
• Weight loss, cachexia

• Virchow's node (left supraclavicular) - Troisier's sign
• Sister Mary Joseph's nodule (umbilical)
• Blumer's shelf (pelvic drop metastasis - felt on PR)
• Krukenberg tumor (ovarian metastasis)
• Irish's node (left axillary)
• Hepatomegaly, ascites, jaundice

Investigations

1. Upper GI Endoscopy + Biopsy (diagnostic gold standard)
2. CT chest/abdomen/pelvis - staging; assess resectability; nodal and liver metastases
3. Endoscopic Ultrasound (EUS) - T and N staging; best for local invasion depth
4. Laparoscopy + peritoneal washings - exclude peritoneal metastasis (CT may miss)
5. FBC (anaemia), LFTs, CEA, CA 19-9, CA 72-4

Management

Surgical (Intent to Cure)

• Subtotal (distal) gastrectomy with at least 5 cm proximal margin
• D2 lymph node dissection (standard in Asia; recommended in West for fit patients): Removes perigastric nodes (D1) + nodes along main arterial trunks (celiac, left gastric, common hepatic, splenic artery)
• Reconstruction: Billroth I, Billroth II, or Roux-en-Y gastrojejunostomy

• D1: Perigastric nodes only
• D2: D1 + nodes along celiac axis branches; recommended standard for potentially curative resection (at least 15 nodes examined)
• Extended (D3): No proven benefit over D2

• Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD): For T1a tumors meeting criteria (well-differentiated, no ulceration, <2 cm)

Perioperative/Neoadjuvant Chemotherapy

• FLOT regimen (Docetaxel, Oxaliplatin, 5-FU, Leucovorin) - current standard in Europe (FLOT4 trial)
  • 4 cycles pre-op + 4 cycles post-op
• ECF/ECX (Epirubicin, Cisplatin, 5-FU/Capecitabine) - MAGIC trial (2006): Improved OS from 23% to 36% at 5 years with perioperative chemotherapy

Adjuvant Therapy

• Chemoradiotherapy after surgery (MacDonald regimen): USA practice
• Adjuvant capecitabine + oxaliplatin (XELOX/CAPOX): Standard in Asia (CLASSIC trial)

Targeted Therapy

• Trastuzumab (anti-HER2) + chemotherapy: HER2-positive advanced gastric cancer (ToGA trial) - ~20% of gastric cancers are HER2+
• Ramucirumab (anti-VEGFR2): 2nd line advanced disease
• Nivolumab/Pembrolizumab (anti-PD1 immune checkpoint inhibitors): MSI-H tumors; PD-L1+ advanced disease; increasingly used in first line (CheckMate 649, KEYNOTE-590 trials)

---

Q9. Recent Advances in Management of Ca Stomach ⭐⭐⭐

1. FLOT chemotherapy replacing ECF as neoadjuvant standard (FLOT4 trial, 2019)
2. Laparoscopic / Robotic-assisted gastrectomy: Non-inferior to open for D2 resection in EGC and advanced GC (JLSSG0901, CLASS-01 trials)
3. ESD (Endoscopic Submucosal Dissection): Allows en-bloc resection of EGC; lower morbidity than surgery
4. HER2 testing now mandatory: Trastuzumab + chemotherapy for HER2+ advanced GC (ToGA trial)
5. Immunotherapy (PD-1/PD-L1 inhibitors): Pembrolizumab + chemotherapy as first-line for MSI-H or PD-L1+ tumors; CheckMate 649 showed OS benefit with nivolumab
6. Peritoneal lavage cytology and HIPEC: Heated Intraperitoneal Chemotherapy for peritoneal metastasis
7. Comprehensive molecular profiling (TCGA classification): EBV+, MSI, CIN, GS subtypes guide treatment
8. Conversion surgery: After downstaging of initially unresectable disease with chemotherapy
9. Watch-and-wait for EGC after ESD: Close endoscopic surveillance replacing radical gastrectomy

---

Q10. Percutaneous Endoscopic Gastrostomy (PEG) (2016/2013) ⭐⭐⭐

Definition

Indications

Contraindications

• Coagulopathy (INR >1.5, platelets <50,000)
• Gastric malignancy at insertion site
• Ascites (relative)
• Previous gastric surgery with altered anatomy
• Active peritonitis
• Interposed colon between stomach and abdominal wall

Technique: Pull Method (Ponsky-Gauderer - Most Common)

1. Upper GI endoscopy performed; stomach insufflated with air
2. Transillumination: Endoscope light seen through anterior abdominal wall confirms safe site (left upper quadrant, 2 cm below costal margin, midway between midline and lateral abdominal wall)
3. Finger indentation test: Assistant presses on abdomen; indentation seen endoscopically confirms proximity of stomach to abdominal wall (no colon or liver interposed)
4. Local anaesthesia injected at skin site
5. Small skin incision made; trocar-cannula passed through abdominal wall and anterior stomach wall into stomach
6. Thread/guidewire passed through cannula into stomach; grasped by endoscope snare
7. Endoscope withdrawn, pulling thread out through mouth
8. PEG tube attached to oral end of thread; pulled back through esophagus and stomach, out through the abdominal wall (pull technique)
9. External bumper/disc placed to secure tube against abdominal wall; internal bumper holds tube inside stomach
10. Tube position confirmed by insufflating air and auscultating over stomach

• Push method (Sacks-Vine): Wire-guided; tube pushed over guidewire
• Introducer method (Russell): No oral passage of tube - used in head and neck cancer to avoid tumor seeding

Complications

• Wound infection (most common; ~10%)
• Peristomal leakage
• Aspiration pneumonia
• Peritonitis (if stomach not adherent)
• Bleeding

• Buried bumper syndrome: Internal bumper migrates into gastric wall
• Tube displacement/blockage
• Gastrocolic fistula
• PEG site granuloma/ulceration
• Tumor seeding at PEG site (in head/neck cancers if pull method used)

---

Q11. Lymphovascular Anatomy of Stomach ⭐⭐⭐

Arterial Supply

1. Left gastric artery (from celiac): Runs along lesser curvature; largest; most important
2. Right gastric artery (from hepatic): Lesser curvature, right side
3. Left gastroepiploic artery (from splenic): Greater curvature, left side
4. Right gastroepiploic artery (from gastroduodenal): Greater curvature, right side
5. Short gastric arteries (4-5 from splenic): Fundus via gastrosplenic ligament

Venous Drainage

• Left gastric (coronary) vein → portal vein (important in portal hypertension; varices)
• Right gastric vein → portal vein
• Left gastroepiploic vein → splenic vein
• Right gastroepiploic vein → superior mesenteric vein

Lymphatic Drainage (Critical for Gastric Cancer Surgery)

• Along lesser curvature (stations 1-4a/4b)
• Along greater curvature (stations 4/5/6)

• Station 7: Left gastric artery
• Station 8: Common hepatic artery
• Station 9: Celiac axis
• Station 10: Splenic hilum
• Station 11: Splenic artery

• Para-aortic (station 16) - no proven benefit of dissection

---

Q12 & Q15. Histology, Physiology of Stomach + Secretory Cells ⭐⭐⭐⭐

Gross Anatomy/Divisions

• Angle of His: Esophagogastric angle - anatomic anti-reflux mechanism
• Angularis incisura: Junction of body and antrum on lesser curvature

Histology - Cell Types by Region

Gastric Acid Secretion - Mechanism

1. Acetylcholine (vagal - via M3 receptors) - most potent; direct + indirect via ECL cells
2. Gastrin (from G cells - via CCK-B receptors) - direct + via ECL histamine
3. Histamine (from ECL cells - via H2 receptors) - potentiates other stimuli; cAMP pathway

Phases of Gastric Secretion

Inhibition of Acid Secretion

• Somatostatin (D cells): Inhibits G cells and parietal cells; released when pH <2
• Secretin (S cells of duodenum): Released by acid in duodenum; inhibits gastrin; stimulates bicarbonate
• GIP (glucose-dependent insulinotropic peptide): Released by fat and glucose; inhibits acid
• Prostaglandins PGE2: Inhibit acid, stimulate mucus/bicarbonate

Gastric Functions

1. Reservoir function: Receives and stores food (1.5-2 L capacity)
2. Mechanical: Grinding and mixing → chyme
3. Digestive: Pepsin (proteolysis); lipase (fat digestion begins)
4. Acid secretion: Bactericidal; activates pepsinogen; aids iron absorption
5. Intrinsic factor secretion: B12 absorption in terminal ileum
6. Hormonal: Gastrin, ghrelin (hunger hormone from fundus)
7. Immunological: Acid kills ingested pathogens

---

Q13. Mechanism of Gastric Juice Secretion + Steady Acid Secretion ⭐⭐⭐⭐

• Basal Acid Output (BAO): 1-5 mEq/hr (acid secreted without stimulation)
• Peak Acid Output (PAO): After maximal pentagastrin stimulation
• BAO:PAO ratio: >0.6 suggests ZES; normal <0.2
• Acid secretion is tonically inhibited by somatostatin even at baseline
• Zollinger-Ellison Syndrome: Gastrinoma produces unregulated gastrin → continuous maximal stimulation of parietal cells → severe peptic ulceration; acid hypersecretion

---

Q14. Techniques of Laparoscopic Distal Gastrectomy (2015 - 20 marks) ⭐⭐⭐

Indications

• Distal gastric cancer (T1-T3, N0-N1)
• EGC not amenable to ESD
• Benign tumors (GIST, adenoma) in distal stomach

Patient Preparation

• Bowel prep, DVT prophylaxis
• General anaesthesia, supine or modified lithotomy (surgeon between legs)
• Ports: 5-port technique (umbilical 10mm camera; 2 × 12mm working ports; 2 × 5mm assistant ports)

Operative Steps

• Diagnostic laparoscopy; peritoneal washings sent
• Ultrasound if tumor not visible

• Open gastrocolic ligament with ultrasonic shears (LigaSure/Harmonic)
• Divide right gastroepiploic vessels at their origin
• Expose inferior border of pancreas and SMV

• Open hepatogastric ligament (lesser omentum)
• Identify, dissect, and divide right gastric artery
• Preserve hepatic branches of vagus nerve (if preserving vagus)

• Lymph node dissection along celiac axis (D2 - stations 7, 8, 9)
• Left gastric artery divided at origin with clips or stapler

• First part of duodenum mobilized
• Divided with endoscopic linear stapler (60 mm, blue/green load)

• Proximal margin marked (5 cm above tumor for advanced; 2 cm for EGC)
• Stomach divided with multiple firings of 60 mm linear staplers
• Specimen placed in retrieval bag

• Intracorporeal Delta-shaped anastomosis (Billroth I delta): Two intersecting stapler firings creating gastroduodenostomy
• Roux-en-Y: Jejunum divided 20 cm from ligament of Treitz; gastrojejunostomy (side-to-side with linear stapler); jejunojejunostomy 40 cm distally; mesenteric defects closed
• Billroth II: Gastrojejunostomy with side-to-side stapler

• Small upper midline or umbilical extension; specimen extracted in bag
• Drain placement; port closure

Advantages of Laparoscopic over Open

• Less post-op pain, earlier recovery
• Lower wound infection, incisional hernia
• Less blood loss
• Shorter hospital stay
• Equivalent oncologic outcomes for T1-T3

---

Q(2019/2021). Surgical Anatomy of SMA & IHSN Syndrome (Superior Mesenteric Artery Syndrome) (8 marks) ⭐⭐

SMA Anatomy

• Origin: Anterior aorta at L1 vertebral level (~1 cm below celiac axis)
• Passes behind the neck of the pancreas and over the uncinate process
• Crosses the duodenum anteriorly (3rd part/D3) - this crossing is important in SMA syndrome
• Supplies entire small bowel (jejunum + ileum) and right colon (to mid-transverse colon)

SMA Syndrome (Wilkie's Syndrome / Cast Syndrome)

• Compression of 3rd part of duodenum between the SMA anteriorly and the aorta/vertebral column posteriorly
• Normally protected by angle of 25-60° between SMA and aorta (the mesenteric angle/aortomesenteric angle)
• In SMA syndrome: Angle narrows to <25° and aortomesenteric distance <8 mm

• Rapid weight loss (loss of mesenteric fat pad)
• Prolonged bed rest/supine position (body cast - hence "cast syndrome")
• Scoliosis, lumbar lordosis surgery
• Eating disorders (anorexia nervosa)

• Postprandial epigastric pain relieved by left lateral decubitus or prone position
• Non-bilious or bilious vomiting
• Weight loss

• Conservative: Nutritional support (TPN/nasojejunal feeding), weight gain
• Surgical: Strong's procedure (division of ligament of Treitz - duodenal mobilization); Duodenojejunostomy (bypasses obstruction)

---

Q(2021). Surgical Anatomy of Thoracoabdominal Diaphragm and Its Surgical Importance (30 marks) ⭐⭐⭐

Anatomy of Diaphragm

• Central tendon: Central aponeurosis (fibrous)
• Muscular portion: From sternal, costal, and lumbar portions

1. Sternal part: From xiphoid process
2. Costal part: From lower 6 ribs (6th-12th)
3. Lumbar part: From crura (right crus from L1-L3 bodies; left crus from L1-L2 bodies) and arcuate ligaments

• Phrenic nerves (C3, C4, C5): Motor + sensory to central diaphragm (C3, 4, 5 keeps the diaphragm alive)
• Lower 6 intercostal nerves: Sensory to peripheral diaphragm

• Superior phrenic arteries (from thoracic aorta)
• Inferior phrenic arteries (from abdominal aorta - first branches)
• Lower intercostal and musculophrenic arteries

1. Foramen of Morgagni (retrosternal/parasternal): Between sternal and costal parts; right side predominantly; Morgagni hernia
2. Foramen of Bochdalek (posterolateral): Failure of pleuroperitoneal membrane closure; most common congenital diaphragmatic hernia (CDH); left side (85%); contains bowel, stomach, spleen
3. Esophageal hiatus: Hiatus hernia (sliding or paraesophageal)

Surgical Importance

• Hiatus hernia (sliding - Type I): GE junction herniates into chest; GERD; medical/surgical Tx (Nissen fundoplication)
• Para-esophageal hernia (Type II-IV): Fundus/other organs herniate while GE junction remains below; risk of strangulation; surgical repair indicated
• Congenital Diaphragmatic Hernia (Bochdalek): Neonatal emergency; lung hypoplasia; repair after stabilization
• Traumatic rupture: More common on left (protected by liver on right); bowel herniation; missed in 50% initially

• Thoracoabdominal incision: Divides diaphragm radially or circumferentially for access to upper abdominal organs (esophagogastric junction, thoracoabdominal aorta)
• Esophagectomy approaches require division/retraction of diaphragm

• During cardiac, thoracic, or neck surgery
• Results in ipsilateral diaphragm paralysis (elevated hemidiaphragm on CXR)
• Can cause respiratory compromise (bilateral injury)

• Collections develop in subphrenic spaces around the diaphragm
• Right: Between liver and diaphragm (right subphrenic and right subhepatic spaces)
• Left: Between stomach/spleen and diaphragm
• Cause: Post-operative (gastrointestinal surgery), perforation

• For unilateral phrenic palsy causing paradoxical movement and breathlessness

• Knowledge of diaphragmatic attachments important to avoid injury during minimally invasive procedures

---

Key References:

• Sabiston Textbook of Surgery - The Biological Basis of Modern Surgical Practice
• Bailey and Love's Short Practice of Surgery, 28th Edition
• Current Surgical Therapy, 14th Edition
• Sleisenger and Fordtran's Gastrointestinal and Liver Disease
• Clinical Gastrointestinal Endoscopy, 3rd Edition
• Costanzo Physiology, 7th Edition

---

Priority Study Guide for STOMACH

Top 5 Most Repeated/High-Mark Topics

• Memorize: Early Dumping vs. Late Dumping distinction
• Know: Afferent loop syndrome (Billroth II specific), Alkaline reflux gastritis, Marginal ulcer
• Management of each complication

• The metabolic alkalosis mechanism is a classic exam question
• Know the paradoxically acidic urine explanation
• Treatment sequence: Resuscitate FIRST → then investigate → then surgery

• PPIs vs. H2RAs mechanism differences are key
• H. pylori triple vs. quadruple therapy regimens with exact drugs and duration
• When to use bismuth quadruple therapy (macrolide resistance criteria)

• All three stimuli of parietal cell (ACh, Gastrin, Histamine)
• Three phases (cephalic 30%, gastric 60%, intestinal 10%)
• Cell types in different regions of stomach

• Virchow's/Sister Mary Joseph/Blumer's shelf/Krukenberg signs
• D1 vs. D2 lymphadenectomy controversy
• FLOT chemotherapy + HER2 testing + immunotherapy

Key Facts to Memorize

• H. pylori: 90% DU, 70-90% GU; test of cure with UBT/SAT 4-6 weeks after treatment
• GOO metabolic: Hypokalemic Hypochloremic Metabolic Alkalosis + paradoxically acidic urine
• Diaphragm openings: T8 (IVC), T10 (esophagus), T12 (aorta)
• Caval opening is in the central tendon (doesn't compress IVC)
• Esophageal hiatus is in the right crus (only right vagal fibers keep it closed)

---

Exam Weightage Guide

---

Q1 (2020) & Q(2018). Physiology of Biliary Secretion, Function of Gallbladder + Physiology of Bile + Significance of LFT in Surgical Patient ⭐⭐⭐⭐⭐

Composition of Bile

---

Bile Salts - Primary and Secondary

• Cholic acid and Chenodeoxycholic acid

• Deoxycholic acid (from cholic acid)
• Lithocholic acid (from chenodeoxycholic acid)

Enterohepatic Circulation of Bile Salts

1. Bile salts secreted into duodenum
2. Aid in fat digestion and absorption (micelle formation) in small intestine
3. 95% actively reabsorbed in the terminal ileum (active sodium-coupled transport)
4. 5% spills into colon → secondary bile acids → partially reabsorbed
5. Return to liver via portal vein → re-secreted into bile
6. Total bile salt pool: 3-5 g, recirculates 2-3 times per meal
7. Interruption (ileal resection, Crohn's ileitis): Bile salt deficiency → fat malabsorption, steatorrhoea, fat-soluble vitamin deficiency

Functions of Bile

1. Fat digestion: Bile salts emulsify fats → form mixed micelles with fatty acids and monoglycerides → facilitate absorption by intestinal enterocytes
2. Fat-soluble vitamin absorption: Vitamins A, D, E, K require bile for absorption
3. Cholesterol excretion: Only route for cholesterol excretion (not metabolized); secreted in bile
4. Bilirubin excretion: Principal route for bilirubin elimination
5. Bicarbonate secretion: Alkalinizes duodenal chyme; protects from peptic digestion
6. Bacteriostatic: Inhibits intestinal bacterial overgrowth
7. Stimulates intestinal motility

Gallbladder Function

1. Concentration: GB concentrates hepatic bile 5-10x by absorbing water and electrolytes (Na+, Cl-, HCO3-) - most important function
2. Storage: Stores 30-50 mL of bile between meals (relaxed state)
3. Secretion: Mucous glands secrete mucus into bile
4. Acidification: GB acidifies bile (H+ secretion) → promotes solubility of calcium salts
5. Absorption of bile acids: Minor amount absorbed in GB
6. Contraction (emptying): Stimulated by CCK (cholecystokinin) - released by fat and protein in duodenum; also by vagal stimulation
7. Relaxation: Inhibited by somatostatin and sympathetic stimulation

---

Significance of Liver Function Tests (LFTs) in Surgical Patient

Aminotransferases (ALT, AST)

• ALT (Alanine aminotransferase): Liver-specific; elevated in hepatocellular damage
• AST (Aspartate aminotransferase): Also in heart, muscle; less liver-specific
• Markedly elevated (>10x): Acute hepatitis, ischemic hepatitis, drug toxicity
• Mildly elevated (1-3x): NAFLD, chronic hepatitis, GERD, right heart failure
• Surgical significance: Very high ALT/AST pre-op → delay elective surgery; risk of acute hepatic failure post-operatively

Alkaline Phosphatase (ALP)

• Found in liver (canalicular membrane), bone, placenta, intestine
• Elevated in cholestatic (biliary) disease (intra- or extrahepatic obstruction)
• Also elevated in: Bone disease (Paget's, metastases), pregnancy
• Isolated ALP elevation → suspect biliary or bone pathology
• Surgical significance: High ALP + high GGT = biliary obstruction → investigate before elective surgery

GGT (Gamma-glutamyltransferase)

• Very sensitive for hepatobiliary disease and alcohol intake
• Elevated in: Cholestasis, alcohol, enzyme-inducing drugs
• Used to confirm hepatic origin of ALP elevation

Bilirubin

• Total bilirubin: Direct (conjugated) + Indirect (unconjugated)
• Elevated direct bilirubin → obstruction or hepatocellular disease
• Surgical significance: Jaundice increases operative risk; elevated bilirubin → renal dysfunction (hepatorenal syndrome), coagulopathy, wound healing impairment, infection risk

Serum Proteins (Albumin, Globulin)

• Albumin: Made exclusively by liver; half-life 20 days; reflects chronic liver synthetic function
• Low albumin (<30 g/L): Poor wound healing, higher infection risk, anastomotic leakage
• Surgical significance: Albumin is one of the strongest predictors of surgical outcome; nutritional optimization required pre-op

Prothrombin Time (PT) / INR

• Reflects synthetic function for clotting factors (II, VII, IX, X - vitamin K dependent)
• Most sensitive indicator of acute liver synthetic failure
• Prolonged PT/INR = impaired liver synthesis → bleeding risk
• Surgical significance: INR >1.5 → significant bleeding risk; requires Vitamin K, FFP, or cryoprecipitate correction before surgery

Liver Surgical Risk Assessment

• Child-Pugh Score (cirrhosis): Bilirubin + Albumin + PT + Ascites + Encephalopathy
  • Class A (5-6): Good risk; Class B (7-9): Moderate; Class C (10-15): Poor - avoid major surgery
• MELD Score (Model for End-stage Liver Disease): Bilirubin + INR + Creatinine
  • Score >15: High operative mortality for elective surgery
  • Score >25: Extremely high risk

---

Q5 & Q14. Bilirubin Metabolism & Pathophysiological Changes in Obstructive Jaundice ⭐⭐⭐⭐⭐

Bilirubin Metabolism - Normal Pathway

• 80% from breakdown of haemoglobin in senescent RBCs (RBC lifespan ~120 days) by reticuloendothelial system (spleen, liver, bone marrow)
• 20% from other haem-containing proteins (myoglobin, cytochrome P450) - "early-labelled bilirubin"
• Haem → Biliverdin (by haem oxygenase) → Unconjugated bilirubin (by biliverdin reductase)
• UCB is insoluble in water, lipid-soluble; transported in blood bound to albumin; cannot be excreted in urine

• UCB dissociates from albumin at the hepatocyte sinusoidal membrane
• Taken up by hepatocytes via organic anion transporters (OATPs)
• Bound intracellularly to ligandin (glutathione S-transferase Y)

• In hepatocyte smooth endoplasmic reticulum
• Catalyzed by UDP-glucuronosyltransferase (UGT1A1)
• UCB + UDP-glucuronic acid → Conjugated (direct) bilirubin (bilirubin diglucuronide = water-soluble)
• Now water-soluble and capable of renal excretion if enters blood

• Active transport across canalicular membrane via MRP2 (multidrug resistance protein 2)
• Excreted into bile canaliculi → bile ducts → CBD → duodenum

• In terminal ileum and colon: Bacterial action → urobilinogen
• Most urobilinogen excreted in feces as stercobilinogen (gives stool brown color) → oxidized to stercobilin
• ~10-20% urobilinogen reabsorbed (enterohepatic circulation) → re-excreted by liver
• ~2-5% urobilinogen enters systemic circulation → excreted in urine as urobilinogen (gives urine yellow color)

---

Types of Jaundice

---

Pathophysiological Changes in Obstructive Jaundice

1. Hepatic Changes

• Intrahepatic cholestasis → bile salt accumulation → hepatocyte injury
• Dilated bile canaliculi and ductules
• Progressive: Biliary cirrhosis (if chronic)
• Kupffer cell dysfunction → reduced bacterial clearance

2. Renal Changes (Very Important Surgically)

• Bile salts are directly nephrotoxic
• Reduced renal blood flow (due to reduced circulating volume, endotoxemia)
• Risk of acute tubular necrosis (ATN) and hepatorenal syndrome
• Endotoxins (from gut, unchecked by Kupffer cells) → renal vasoconstriction
• Prevention: IV mannitol (osmotic diuresis) preoperatively; IV fluids; lactulose to reduce endotoxin absorption; oral bile salts to restore gut barrier

3. Coagulation Abnormalities

• Vitamin K malabsorption (fat-soluble; requires bile for absorption)
• Reduced synthesis of factors II, VII, IX, X
• Prolonged PT/INR → bleeding risk
• Management pre-op: Vitamin K 10 mg IV for 3 days; if inadequate response, check for hepatocellular dysfunction; FFP if urgent surgery

4. Immune Dysfunction / Increased Infection Risk

• Absent bile in intestine → reduced IgA secretion → impaired gut barrier
• Endotoxin absorption from gut lumen → bacteremia, sepsis
• Kupffer cell dysfunction
• Risk of: Cholangitis, wound infection, hepatic abscess

5. Cardiovascular Changes

• Bradycardia (bile salts depress cardiac conduction)
• Hypotension (reduced vasomotor tone)
• Increased risk of intraoperative cardiac arrest

6. Wound Healing Impairment

• Low albumin (synthetic dysfunction) → poor collagen synthesis
• Vitamin deficiencies (A, D, E, K)

7. Malnutrition

• Fat malabsorption → steatorrhoea
• Fat-soluble vitamin deficiency (A, D, E, K)
• Weight loss, muscle wasting

8. Pruritis

• Bile salt deposition in skin → intense itching
• Management: Cholestyramine, rifampicin

Summary: Pre-operative Optimization for Obstructive Jaundice

1. Correct coagulopathy: Vitamin K (IV), FFP if urgent
2. Renal protection: IV fluids, mannitol pre-op, lactulose
3. Nutritional optimization: Parenteral/enteral nutrition
4. Treat cholangitis first (IV antibiotics)
5. Biliary drainage before major surgery if bilirubin >200 µmol/L (PTBD or ERCP stenting)
6. Prophylactic antibiotics at induction

---

Q4 & Q13 & Q15. Surgical Anatomy of GB, CBD + Biliary Tract ⭐⭐⭐⭐⭐

Gallbladder Anatomy

• Fundus: Most distal, projects beyond liver edge; touchable at right costal margin at MCL (Murphy's point); covered by peritoneum
• Hartmann's pouch: Outpouching at the neck - gallstones frequently lodge here; can compress the CBD (Mirizzi syndrome)
• Cystic duct: Length 2-4 cm; connects neck to CBD; lined by spiral mucosal folds (valves of Heister)

• Superior: Liver (quadrate lobe)
• Inferior: First part duodenum, hepatic flexure of colon
• Anterior: Anterior abdominal wall (fundus)

• Cystic artery: Usually a branch of the right hepatic artery; courses through the Triangle of Calot (cystohepatic triangle)
• Variations: Cystic artery may arise from left hepatic, common hepatic, gastroduodenal, or directly from celiac axis - extremely important to identify correctly during cholecystectomy

---

Triangle of Calot (Cystohepatic Triangle) - MOST IMPORTANT LANDMARK

• Medial: Common hepatic duct
• Lateral/Superior: Cystic duct (lower boundary)
• Superior: Inferior surface of liver (right lobe)

• Cystic artery (identified and divided here)
• Cystic lymph node (Lund's node)
• Occasionally: Aberrant right hepatic artery

---

Common Bile Duct (CBD) - Anatomy

1. Supraduodenal: From junction of cystic duct + common hepatic duct (CHD) → upper border of duodenum; runs in free edge of lesser omentum (hepatoduodenal ligament)
2. Retroduodenal: Behind first part of duodenum
3. Pancreatic: Runs through or behind the head of pancreas (groove)
4. Intraduodenal (intramural): Passes obliquely through wall of 2nd part of duodenum; unites with main pancreatic duct (Wirsung) at the ampulla of Vater; controlled by sphincter of Oddi

• Anterior: CBD (right) + hepatic artery proper (left) - "the two pillars of the portal triad"
• Posterior: Portal vein (most posterior)
• CBD: Right side; Hepatic artery: Left side; Portal vein: Posterior

• Smooth muscle sphincter surrounding distal CBD + PD at ampulla
• Maintains basal tone preventing bile/pancreatic juice reflux
• Relaxes during GB contraction (CCK-mediated) to allow bile flow
• Basal pressure ~13 mmHg; prevents duodenobiliary reflux

---

Extrahepatic Biliary Ducts (Full Anatomy)

• Right hepatic duct + left hepatic duct → Common hepatic duct (CHD) (joins at hepatic hilum)
• CHD + cystic duct → Common bile duct (CBD)
• CHD length ~4 cm; CBD length ~8-10 cm
• Entire extrahepatic biliary tree from hilum to duodenum = ~12-15 cm

---

Q4 (cont.). Management of Acute Cholecystitis ⭐⭐⭐⭐⭐

Pathophysiology

• Obstruction of cystic duct by stone → GB distension → mucosal ischemia → chemical/bacterial inflammation
• 90% of cases associated with gallstones (acute calculous cholecystitis)
• 10%: Acute acalculous cholecystitis - critically ill patients (ICU, post-major surgery, trauma, burns) - worse prognosis

Clinical Features

• Severe RUQ/epigastric pain (constant, not colicky - distinguishes from biliary colic)
• Pain radiating to right shoulder/interscapular area
• Fever (38-38.5°C), nausea, vomiting
• Murphy's sign: Arrest of inspiration when palpating RUQ (pressure on inflamed GB causes pain) - 95% specific when positive
• Tenderness + guarding in RUQ
• Palpable mass (GB empyema or pericolecystic collection) in 30%

• Fever + RUQ pain + Jaundice

• Charcot's triad + Hypotension + Confusion/Altered mental status

Investigations

1. Ultrasound abdomen - investigation of choice: Calculi, thickened GB wall (>4 mm), pericholecystic fluid, positive sonographic Murphy's sign, CBD dilatation
2. Blood tests: FBC (leukocytosis), LFTs (mildly raised ALP, bilirubin), CRP (elevated)
3. CT abdomen: Complications - perforation, gangrenous cholecystitis, pericholecystic abscess, emphysematous cholecystitis
4. HIDA scan (cholescintigraphy): If US equivocal; non-filling of GB = cystic duct obstruction - most sensitive
5. MRCP: If CBD stones suspected (dilated CBD, jaundice)
6. Blood cultures: If fever, sepsis

Tokyo Guidelines (TG18) - Severity Grading

• Grade I (Mild): No organ dysfunction, no severe local inflammation
• Grade II (Moderate): WBC >18,000, palpable tender mass, >72 hrs symptoms, marked local inflammation
• Grade III (Severe): Organ dysfunction (cardiovascular, neurological, respiratory, renal, hepatic, haematological)

Management

Initial (All Grades):

• IV fluids, nil-by-mouth
• IV analgesia (diclofenac IM/IV reduces GB pressure and spasm; opioids)
• IV antibiotics: Gram-negative coverage + anaerobes (e.g., piperacillin-tazobactam, cefuroxime + metronidazole)
• Proton pump inhibitor
• Monitor: Urine output, temperature, blood tests

Definitive Treatment:

• Tokyo Guidelines TG18 recommendation: Early lap cholecystectomy for Grade I and II
• Lower conversion rate, shorter hospital stay, cost-effective compared to delayed surgery
• Timing: Within 72 hours of symptom onset (before inflammatory mass forms)

• For Grade III (severe) or high-risk surgical patients
• Ultrasound/CT-guided drainage of GB under local anaesthesia
• Provides temporary relief; interval cholecystectomy after recovery

• After initial conservative management if surgery not done early
• Traditional approach (increasingly replaced by early surgery)

---

Q2. Anomalies of Gallbladder and CBD (20 marks) ⭐⭐⭐

Anomalies of the Gallbladder

• Agenesis: Absent GB (rare, ~1 in 7,500); associated with other anomalies
• Duplication: Double GB - each with its own cystic duct; incidentally found; need both removed if symptomatic
• Triple GB: Extremely rare

• Left-sided GB (situs inversus or isolated): Associated with biliary anomalies; higher CBD injury risk
• Intrahepatic GB: Completely buried within liver parenchyma; higher risk during cholecystectomy
• Floating/Pedunculated GB: Long mesentery; prone to torsion; presents as acute abdomen

• Phrygian cap deformity: Fundus folded back on itself (like Phrygian cap); usually incidental; no clinical significance
• Hartmann's pouch: Normal variant (prominent outpouching at neck); clinically significant - stones lodge here

• Porcelain gallbladder: Calcification of GB wall; previously thought high cancer risk - now reassessed (risk lower than historical reports); most treated conservatively unless symptomatic
• Adenomyomatosis: Hyperplastic change of GB wall; Rokitansky-Aschoff sinuses

Anomalies of the Bile Ducts (Critical for Surgery!)

1. Short cystic duct: High risk of clipping common hepatic duct
2. Long cystic duct: Runs parallel to CBD for a long distance before joining
3. Low insertion of cystic duct: Joins CBD very close to the ampulla
4. Medial insertion: Cystic duct crosses posteriorly to join on left side of CBD - risk of misidentification
5. Absence of cystic duct: Direct insertion of GB into CBD

• Accessory hepatic duct: Extra duct draining segment of liver directly into GB/CBD/cystic duct
• Aberrant right hepatic duct: Drains into CHD, CBD or cystic duct at a low level; if damaged during cholecystectomy → bile leak
• Low confluence: Right and left hepatic ducts join low (close to GB bed) - risk of injury

• Caterpillar hump artery (Moynihan's hump): Right hepatic artery loops into triangle of Calot - can be confused with cystic artery
• Double cystic artery
• Cystic artery arising from left hepatic, GDA, or celiac
• Anterior position of right hepatic artery - at risk during cholecystectomy

---

Q3. Interventional Radiology of GB - ERCP and MRCP ⭐⭐⭐

ERCP (Endoscopic Retrograde Cholangiopancreatography)

• CBD stones (choledocholithiasis) - therapeutic
• Cholangitis requiring bile drainage
• Bile duct stricture (diagnostic + stenting)
• Biliary leak (post-cholecystectomy) - stenting
• Choledochal cyst evaluation
• Ampullary tumors (diagnostic)
• Pre-operative decompression in malignant obstructive jaundice
• Sphincter of Oddi manometry

1. Patient sedated; side-viewing duodenoscope (TJF-type) used
2. Papilla of Vater identified in 2nd part of duodenum
3. Cannula introduced into papilla; contrast injected under fluoroscopy
4. Biliary and/or pancreatic ducts outlined
5. Therapeutic interventions performed:
   • Endoscopic sphincterotomy (EST): Cutting the sphincter of Oddi with an electrosurgical wire (sphincterotome) → opens the distal CBD → stones pass or removed with Dormia basket/balloon
   • Stone extraction: Dormia basket or balloon catheter
   • Stent insertion: Plastic or metal stent for strictures, malignant obstruction
   • Nasobiliary drain: For cholangitis/bile leak

• Pancreatitis (most common, 3-5%): Usually mild and self-limiting
• Bleeding (post-sphincterotomy)
• Cholangitis
• Perforation (retroduodenal or duodenal)
• Contrast reactions
• Overall morbidity 5-10%; mortality ~0.1-0.2%

---

MRCP (Magnetic Resonance Cholangiopancreatography)

• Suspected CBD stones before laparoscopic cholecystectomy
• Evaluation of biliary strictures
• Choledochal cyst characterization
• Bile duct injury assessment
• Primary sclerosing cholangitis (PSC)
• Pancreatic duct pathology (chronic pancreatitis, IPMN)
• Pre-operative biliary anatomy mapping

• Non-invasive; no radiation; no risk of pancreatitis
• No contrast needed (uses T2 signal from bile)
• 3D reconstruction; full anatomical mapping
• Views hepatic ducts above strictures (ERCP cannot pass stricture)

• Purely diagnostic - no therapeutic capability
• Lower spatial resolution than direct cholangiography
• Cannot visualize small stones <3 mm

• If therapeutic intervention is planned: ERCP first (diagnostic + therapeutic in one)
• If diagnosis needed without intervention: MRCP (safer)
• Modern protocol: MRCP to diagnose CBD stones → ERCP if confirmed (for stone extraction)

---

Q6 (2014). Endoscopy vs. Laparoscopy for CBD Stone (Transcystic + Transcholedochal + ERCP) ⭐⭐⭐⭐

Background

Option 1: Preoperative ERCP + Endoscopic Sphincterotomy + Stone Extraction → Laparoscopic Cholecystectomy

1. ERCP performed (see Q3)
2. Sphincterotomy: Electrosurgical incision of sphincter of Oddi
3. Stone extracted with Dormia basket (wire basket) or balloon catheter
4. Cholangiogram to confirm clearance
5. Laparoscopic cholecystectomy planned separately (same admission or interval)

---

Option 2: Laparoscopic Common Bile Duct Exploration (LCBDE) - Single-Stage Approach

A. Transcystic Route (Preferred if feasible)

1. Intraoperative cholangiogram (IOC) performed first to confirm CBD stones
2. Guidewire passed through cystic duct into CBD
3. Cystic duct dilated with balloon dilator (serial dilators or balloon up to 8 mm)
4. 4 mm flexible choledochoscope introduced through cystic duct into CBD
5. Stones visualized under direct vision
6. Stone fragmented if needed (laser lithotripsy / electrohydraulic lithotripsy)
7. Stones extracted with Dormia basket under choledochoscopic view
8. Completion cholangiogram to confirm clearance
9. Cystic duct ligated and divided; cholecystectomy completed
10. No T-tube needed (cystic duct closure)

B. Transcholedochal Route (Choledochotomy)

1. CBD identified in hepatoduodenal ligament
2. Stay sutures placed on anterior CBD wall
3. Longitudinal choledochotomy 10-15 mm in supraduodenal CBD
4. Stones milked out manually or extracted with Dormia basket/forceps
5. Flexible choledochoscope inserted to confirm clearance and visualize intrahepatic ducts
6. Residual stones: Balloon sweep, lithotripsy
7. T-tube drainage (Kehr's tube) inserted through choledochotomy:
   • Short arm in CBD (pointing up and down); long arm exits abdomen
   • Functions: Decompresses CBD; maintains lumen; route for post-op cholangiogram; extraction of residual stones
8. T-tube cholangiogram at 7-10 days post-op to confirm clearance
9. T-tube removed at 10-14 days if cholangiogram clear

• Increasingly used; CBD closed directly over choledochoscopy port
• Requires bile duct ≥8 mm, no distal obstruction, complete stone clearance, good tissue quality

• Bile leak
• Stricture at choledochotomy site (long-term)
• CBD injury
• T-tube dislodgement/biloma

---

Comparison Table: ERCP vs. Laparoscopic CBD Exploration

---

Q9 (2014) & Q (2014). Technique of Open and Laparoscopic Cholecystectomy + Different Methods of Cholecystectomy ⭐⭐⭐⭐⭐

Methods of Cholecystectomy

1. Open cholecystectomy (conventional)
2. Laparoscopic cholecystectomy (gold standard)
3. Single-incision laparoscopic cholecystectomy (SILS)
4. Robotic-assisted cholecystectomy
5. Natural orifice transluminal endoscopic surgery (NOTES) - experimental
6. Mini-laparotomy cholecystectomy (mini-chol) - 5-7 cm incision; developing world

---

A. Laparoscopic Cholecystectomy (Gold Standard) ⭐⭐⭐⭐⭐

1. 10 mm umbilical port (Hasson or Veress technique): Camera port
2. 10-12 mm epigastric port (4 cm below xiphoid, right of midline): Main working port; clip applicator
3. 5 mm right subcostal port (MCL): Retraction port
4. 5 mm right flank port: Retraction of GB fundus

• Veress needle at umbilicus (or open Hasson technique for prior surgery/suspected adhesions)
• Insufflate with CO2 to 12-14 mmHg
• 10 mm trocar inserted; 30° angled scope introduced

• Patient tilted: Head-up + left lateral → liver falls up and away; GB exposed
• Fundus grasped and retracted superiorly (cephalad) by fundal grasper
• Hartmann's pouch grasped and retracted laterally (to open triangle of Calot)

• Peritoneum on anterior and posterior aspects of triangle of Calot incised
• Fundus-first retraction (antegrade/lateral retraction): Hartmann's pouch pulled laterally → opens the triangle
• Dissection with hook diathermy/scissors + suction/irrigation
• Fat and areolar tissue cleared until Critical View of Safety (CVS) achieved:
  • Lower third of GB dissected free from GB bed (liver)
  • Only 2 structures seen entering GB: Cystic artery + cystic duct
  • Both structures clearly separated from CBD

• Once CVS achieved: 2 clips proximally + 1 clip distally on cystic artery → divide between
• 2 clips proximally + 1-2 clips distally on cystic duct → divide between
• Intraoperative cholangiogram may be performed through cystic duct before clipping (selective or routine)

• GB dissected from liver bed with hook diathermy working from cystic duct/artery clipped ends toward fundus
• Hemostasis of GB bed

• GB placed in retrieval bag (Endobag)
• Extracted through 10 mm umbilical port (or epigastric if GB large/stones)
• Spillage avoided; if spilled, stones washed and retrieved (dropped stones → abscess years later)
• Abdominal cavity irrigated; hemostasis checked

• 10/12 mm port sites closed with fascial closure (Endoclose or J-needle)
• Skin closed with subcuticular sutures
• Operative time: 45-75 minutes

---

B. Open Cholecystectomy

• Kocher's (right subcostal) incision: Extends from midline 2-3 cm below xiphoid obliquely to right, parallel to costal margin; excellent GB exposure; standard for open cholecystectomy
• Right paramedian incision: Older approach
• Midline laparotomy: When uncertainty or emergency

1. Kocher incision; liver retracted superiorly with retractor
2. Fundus grasped; GB exposed
3. Triangle of Calot dissected; cystic duct and artery identified
4. Retrograde (fundus-down) or antegrade (fundus-first) dissection
5. Cystic artery ligated and divided; cystic duct ligated with 2/0 Vicryl and divided
6. Intraoperative cholangiogram via cystic duct (if routine policy)
7. GB removed from liver bed with diathermy
8. Drain placed in subhepatic space (optional)
9. Closure in layers (mass closure vs. layered)

• Unclear anatomy (cannot achieve CVS)
• Severe adhesions/fibrosis
• Suspected GB cancer
• Uncontrolled bleeding
• CBD injury
• Bile duct anomaly requiring open reconstruction
• Perforation of abdominal organ

---

Q10 (2015/2018). CF, Ix & Management of Choledochal Cyst ⭐⭐⭐⭐

Definition

Etiology

• Anomalous Pancreaticobiliary Ductal Junction (APBDJ): Long common channel where the pancreatic duct joins the CBD outside the duodenal wall (>10 mm long channel outside sphincter of Oddi) → allows reflux of pancreatic secretions into biliary tree → protein plugs obstruct junction → distal obstruction → cystic dilatation
• Weakness of the biliary wall at the junction
• More common in Asian populations and females (3:1 female:male)

Todani Classification (5 Types)

Clinical Features

1. RUQ pain
2. Jaundice
3. Palpable RUQ mass

• Cholangitis (recurrent)
• Gallstones (within cyst)
• Pancreatitis
• Biliary cirrhosis (chronic)
• Cholangiocarcinoma (most feared): Risk up to 15-20% lifetime (higher with intrahepatic involvement - up to 75% in some Japanese series); risk persists even after drainage procedures (hence complete excision required)
• Portal hypertension (if biliary cirrhosis)

Investigations

1. Ultrasound: First-line; shows cystic biliary dilatation, relationship to pancreas
2. MRCP: Investigation of choice; non-invasive; defines anatomy of APBDJ; type classification; extent
3. CT abdomen: Staging; local invasion; vascular anatomy
4. ERCP: Shows APBDJ; therapeutic in Type III (sphincterotomy)
5. HIDA scan: Biliary function, bile leakage post-op

Operative Management

Type I: Complete excision + Roux-en-Y hepaticojejunostomy

1. Cholecystectomy first
2. Kocher maneuver to expose distal CBD and cyst
3. Identify distal extent of cyst at junction with pancreatic duct (intraoperative US helpful)
4. Transect CBD distally (as close to pancreatic duct as possible without entering pancreas)
5. Mobilize cyst superiorly to level of common hepatic duct bifurcation
6. Transect at confluence (or higher if abnormal mucosa)
7. Roux-en-Y hepaticojejunostomy (or hepaticoduodenostomy in children):
   • Roux limb 40-60 cm; anastomosis between hepatic duct remnant and jejunum
   • End-to-side anastomosis; single layer absorbable sutures

Type II: Diverticulectomy and closure of biliary wall

Type III (Choledochocele): Endoscopic sphincterotomy (usually sufficient); rarely surgical excision

Type IVa: Extrahepatic component excised + Roux-en-Y HJ; intrahepatic component monitored; hepatic resection if localized

Type V (Caroli's Disease):

• Segmental disease: Hepatic resection (lobectomy)
• Diffuse disease: Liver transplantation (only cure)

---

Q11 (2016). Etiology, CF & Ix of CBD Stones + ERCP + Laparoscopic Exploration ⭐⭐⭐⭐⭐

Etiology of CBD Stones

• Brown pigment stones: Infection with E. coli → β-glucuronidase deconjugates bilirubin; associated with biliary stasis, stricture, Caroli's disease, choledochal cyst
• More common in Asian populations (recurrent pyogenic cholangitis)

• Most common in Western countries
• Cholesterol or black pigment stones originally from GB → pass through cystic duct into CBD

• Gallstones in GB (most important risk factor)
• Biliary stricture
• Choledochal cyst
• Caroli's disease
• Post-cholecystectomy (retained stones)
• Parasitic infestation (Clonorchis sinensis, Ascaris - cause pigment stones)
• Haemolysis (black pigment stones)

Clinical Features

• Often asymptomatic (incidentally found on USS)
• Biliary colic: Intermittent RUQ or epigastric pain radiating to back/right shoulder
• Obstructive jaundice: Deep jaundice, pale stools, dark urine, pruritus (if complete obstruction)
• Cholangitis (Charcot's triad): Fever + jaundice + RUQ pain
• Pancreatitis: Stone impacted at ampulla → acute pancreatitis

Investigations

1. LFTs: Raised ALP, GGT, bilirubin (conjugated); AST/ALT mildly elevated
2. Ultrasound: CBD dilatation (>8 mm); stones seen in ~50% (gas-filled duodenum obscures distal CBD)
3. MRCP: Best non-invasive; 95% sensitivity for CBD stones; defines size, number, location
4. EUS (Endoscopic Ultrasound): 95-98% sensitivity; useful for small stones missed on MRCP; CBD scanned from duodenum
5. ERCP: Diagnostic + therapeutic; reserved when therapeutic intent
6. Intraoperative Cholangiogram (IOC): During cholecystectomy - definitive; shows CBD, filling defects

Management

---

Q12 & Q15. Classification & Management of Iatrogenic Bile Duct Injury (BDI) ⭐⭐⭐⭐⭐

Incidence

• Open cholecystectomy: 0.1-0.2%
• Laparoscopic cholecystectomy: 0.3-0.7% (higher than open - loss of tactile feedback, perspective errors)

Mechanisms of BDI During Laparoscopic Cholecystectomy

1. Misidentification error: CBD mistaken for cystic duct (especially when cystic duct is short and CBD is mistakenly clipped as cystic duct)
2. Tenting/traction: Excessive lateral traction on Hartmann's pouch tents up the CBD into the operative field → "tenting injury" - CBD lifted and clipped
3. Thermal injury: Diathermy heat spread to CBD
4. Clip misplacement: Clip placed across CBD
5. Failure to achieve Critical View of Safety
6. Excessive dissection deep to triangle of Calot
7. Bleeding → hasty clipping/diathermy → CBD injury

• Achieve Critical View of Safety (CVS) BEFORE clipping
• Routine intraoperative cholangiogram (IOC) - identifies bile ducts before division
• Fundus-first (top-down) approach for difficult cases
• Low threshold for conversion to open
• Experienced assistance
• Use of fluorescence imaging (ICG cholangiography - near-infrared)

---

Classification Systems

Strasberg Classification (Most Widely Used)

Bismuth-Strasberg Classification (Strictures)

Management of BDI

A. Intraoperative Recognition (Best Scenario)

• Clip application or suture
• Subhepatic drain

• Primary repair over T-tube (if injury <50% circumference and healthy tissue)
• T-tube left for 6 weeks; T-tube cholangiogram before removal

• If low (E1-E2) and <1 cm loss:
  • End-to-end repair over T-tube (if no tension, healthy ends) - poor long-term results; stricture rate high
  • PREFERRED: Roux-en-Y hepaticojejunostomy - much better long-term patency
• If high (E3-E5) or significant tissue loss:
  • Roux-en-Y hepaticojejunostomy at the appropriate level
  • May need bilateral (right + left duct) anastomoses for E4/E5
• If inadequate expertise: Place drains, close → refer to HPB center

B. Delayed Recognition (Postoperative)

1. Resuscitate; CT for collections
2. Drain collections percutaneously
3. ERCP + sphincterotomy + stent → reduces CBD pressure → promotes cystic duct/minor leak closure
4. HIDA scan to confirm leak sealed
5. Surgery only if ERCP fails or major injury

1. MRCP / PTC to define level and extent
2. Percutaneous transhepatic cholangiography + drainage (PTCD): Decompresses biliary tree; treats cholangitis; defines anatomy
3. Definitive repair: Roux-en-Y hepaticojejunostomy at the HPB center (best outcomes)
4. Endoscopic balloon dilatation + stenting: For low Bismuth I-II strictures; needs repeated procedures
5. Outcome: 85-90% long-term success with surgical repair at specialist centers

---

Q (2021). Mirizzi Syndrome ⭐⭐⭐⭐ (10 marks)

Definition

Pathophysiology

1. Large stone impacted in Hartmann's pouch or cystic duct
2. Stone compresses the adjacent CHD → partial or complete biliary obstruction
3. With time, pressure necrosis → erosion through GB wall and CHD wall → cholecystocholedochal fistula

McSherry Classification

Clinical Features

• Obstructive jaundice (can be partial or complete)
• Recurrent cholangitis, fever
• RUQ pain
• History of cholelithiasis
• Mimics cholangiocarcinoma clinically and radiologically

Investigations

• MRCP: Best for preoperative diagnosis; shows characteristic appearance of extrinsic compression at level of CHD with intraluminal stones; sparing of the CBD below
• ERCP: Diagnostic + therapeutic (stenting); shows level of obstruction
• EUS: Helpful
• CT: May show but MRCP is superior
• Preoperative diagnosis rate: Only 8-62% (often diagnosed intraoperatively)

Management

• Laparoscopic or open cholecystectomy (depends on expertise and inflammation)
• Partial cholecystectomy leaving posterior GB wall on CHD (safer)
• Often requires open surgery due to severe inflammation

• Partial cholecystectomy
• Stone removed from CHD
• Small defect: Primary closure over T-tube
• Large defect: Roux-en-Y hepaticojejunostomy

• Open surgery mandatory
• Complete removal of GB + bile duct reconstruction
• Roux-en-Y hepaticojejunostomy (standard for Types III-IV)

• Repair cholecystoenteric fistula + biliary reconstruction

---

Q (2016/2025). Biliary Fistula (10 marks) ⭐⭐⭐

Definition

Classification

1. Cholecystoduodenal fistula (most common internal - 60-75%): Between GB and duodenum; complication of chronic cholecystitis and gallstones; may cause gallstone ileus (stone >2.5 cm passes through fistula → obstructs ileocaecal valve)
2. Cholecystocolic fistula: Between GB and colon; causes chronic diarrhea, fat malabsorption, loss of bile salts
3. Choledochoduodenal fistula: CHD/CBD to duodenum; chronic cholangitis
4. Cholecystogastric fistula: Rare

1. Post-operative: After cholecystectomy (cystic duct stump leak, CBD injury, dropped stone) - most common cause of external biliary fistula today
2. Post-traumatic: Liver trauma
3. Spontaneous (rare): Chronic empyema of GB eroding through abdominal wall; or after hepatic abscess drainage

Investigations

• ERCP / MRCP: Define anatomy of fistula
• HIDA scan: Confirms bile leak, shows fistula tract
• Fistulogram: Inject contrast into external fistula
• Bloods: LFTs, bilirubin; amylase if associated with pancreatitis
• CT abdomen: Collections, pneumobilia (air in biliary tree), fistula tract

Management

1. Resuscitate + drain collections (percutaneous)
2. ERCP + sphincterotomy + stent → reduces biliary pressure → minor leaks close
3. Most Type A (minor) leaks close with ERCP stenting alone
4. Surgery (Roux-en-Y HJ) only for major injuries or failure of ERCP

1. Elective surgery (if symptomatic): Close fistula + cholecystectomy
2. Gallstone ileus: Emergency laparotomy; enterotomy + stone removal; cholecystectomy + fistula closure at same or separate sitting

---

Q (2014). Biliary Enteric Anastomosis (10 marks) ⭐⭐⭐

Indications

1. CBD stricture (benign: post-cholecystectomy injury, chronic pancreatitis; malignant: cholangiocarcinoma, pancreatic Ca)
2. Choledochal cyst excision
3. Chronic choledocholithiasis (elderly, recurrent)
4. Post-BDI reconstruction
5. Palliative bypass for unresectable pancreatic/biliary cancer

Types

1. Choledochoduodenostomy (CDD)

• Side-to-side anastomosis between CBD and 1st part of duodenum
• Advantages: Simple, no bowel division, good blood supply
• Disadvantages: "Sump syndrome" - food and debris collect in blind distal CBD segment between duodenum and sphincter → infection/stone formation; reflux gastritis
• Use: Elderly patients with benign obstruction; low-risk reconstruction

2. Choledochojejunostomy

• CBD to defunctionalized Roux loop of jejunum
• Less reflux than CDD
• Rarely used as isolated procedure

3. Roux-en-Y Hepaticojejunostomy (HJ) - GOLD STANDARD ⭐

• Most widely used biliary reconstruction
• End-to-side anastomosis between common hepatic duct/right+left hepatic ducts and Roux limb of jejunum (40-60 cm Roux limb to prevent reflux)
• Advantages: Low reflux; excellent long-term patency; adaptable to any level; can be right + left duct if needed
• Disadvantages: Complex; requires two anastomoses (bilioenteric + jejunojejunostomy)
• Technique:
  1. Identify CHD stump or hepatic duct at appropriate level
  2. Jejunum divided 40 cm from ligament of Treitz
  3. Roux limb brought up retrocolic (through mesocolon) or antecolic
  4. End-to-side anastomosis: Posterior wall first with 3/0 or 4/0 PDS (absorbable); then anterior wall
  5. Single layer anastomosis preferred; interrupted sutures at the posterior wall
  6. Jejunojejunostomy (Roux-en-Y anastomosis) 40-60 cm distally

4. Hepaticoduodenostomy

• Hepatic duct to duodenum
• Used in children after choledochal cyst excision
• Risk of reflux over time → rarely used in adults

5. Intrahepatic Bilioenteric Anastomosis (Hutson-Blumgart)

• For high Bismuth IV/V injuries
• Left hepatic duct exposed via segment III approach (lowering the hilar plate)
• Anastomosis to Roux loop
• For cases where hilar approach impossible

---

Q (2014). Mx of Intrahepatic Bile Duct Stones (15 marks) ⭐⭐⭐

Definition

Etiology

• Recurrent pyogenic cholangitis (RPC): Bacterial infection (E. coli, Klebsiella) → β-glucuronidase → calcium bilirubinate stones + mud
• Caroli's disease (congenital)
• Primary sclerosing cholangitis (PSC)
• Biliary strictures
• Liver fluke infestation (Clonorchis sinensis)

Clinical Features

• Recurrent episodes of: Right upper quadrant pain + fever (cholangitis) + jaundice
• Eventually: Hepatic abscess, secondary biliary cirrhosis, portal hypertension
• Risk of cholangiocarcinoma (especially in PSC and Caroli's)

Investigations

• LFTs, blood cultures (during acute attacks)
• Ultrasound + MRCP (best non-invasive; shows extent, strictures)
• CT: Hepatic atrophy, stones, strictures
• ERCP/PTC: Decompression during acute cholangitis + define anatomy

Management

• IV antibiotics + biliary decompression (ERCP/PTCD)
• Percutaneous hepatic drainage for hepatic abscess

• Percutaneous access to intrahepatic ducts
• Flexible cholangioscope introduced; stones fragmented with lithotripsy (laser/EHL)
• Stone clearance under direct vision

• Left lateral or left hepatic resection (stones most common in left lobe in Asian patients due to anatomy)
• Removes stone-containing segment + irreversibly damaged/atrophic parenchyma
• Combination with biliary reconstruction (HJ) if stricture at confluence

• For end-stage PSC with cirrhosis or Caroli's disease with diffuse involvement

---

Summary: Priority Study Order for Exam

THE BIG 5 (Must master):

1. Bile duct injury - classification (Strasberg/Bismuth), mechanism, prevention, management
2. Laparoscopic cholecystectomy - full technique with Critical View of Safety
3. CBD stones - ERCP vs. transcystic vs. transcholedochal
4. Obstructive jaundice - bilirubin metabolism + all pathophysiological changes
5. LFTs in surgical patient - each test, what it means, surgical significance

High-Yield Facts to Memorize:

• CVS (Critical View of Safety): Only 2 structures entering GB before clipping
• Strasberg Type A = most common post-lap-chol bile leak (cystic duct stump) → ERCP + stent
• Bismuth I-V stricture levels (E1-E5 in Strasberg)
• Gold standard biliary reconstruction = Roux-en-Y hepaticojejunostomy with 40-60 cm Roux limb
• Choledochal cyst: Complete excision mandatory (not drainage) due to cholangiocarcinoma risk
• Mirizzi: External compression of CHD by stone in cystic duct/Hartmann's pouch
• Charcot's triad: CBD stone + cholangitis; Reynolds pentad: + hypotension + confusion = septic cholangitis
• T-tube functions: Decompression + lumen maintenance + route for post-op cholangiogram + stone extraction

References:

• Bailey and Love's Short Practice of Surgery, 28th Edition
• Sabiston Textbook of Surgery
• Current Surgical Therapy, 14th Edition
• Blumgart's Surgery of the Liver, Biliary Tract and Pancreas
• Schwartz's Principles of Surgery

---

Exam Weightage at a Glance

---

Q1/Q2. Enterocutaneous Fistula (ECF) / Post-op SI Fistula - Assessment, Monitoring & Management ⭐⭐⭐⭐⭐

Definition

Etiology

• Anastomotic leak (most common cause)
• Inadvertent enterotomy during adhesiolysis
• Devascularized anastomosis
• Tension on anastomosis
• Distal obstruction

• Crohn's disease (most common non-iatrogenic cause)
• Radiation enteritis
• Malignancy (eroding into bowel)
• Ileocaecal TB
• Diverticular disease
• Actinomycosis

• F - Foreign body (mesh, suture, drain)
• R - Radiation
• I - Infection/Inflammation (Crohn's, TB)
• E - Epithelialization of fistula tract
• N - Neoplasm
• D - Distal obstruction
• S - Short tract (<2 cm) or Steroids

Classification

• High output: >500 mL/24 hr (proximal small bowel - jejunal)
• Low output: <200 mL/24 hr (distal ileum, colon)
• Moderate: 200-500 mL/24 hr

• Simple: Short straight tract, no adjacent complications
• Complex: Abscess, multiple fistulae, irradiated bowel, malignancy

---

Assessment

• Post-operative day of onset (most ECFs present day 5-10)
• Output volume, character (bile-stained = high/proximal; feculent = low/distal)
• Nutritional status pre-op; previous radiation
• Known IBD, TB, malignancy

• Fistula orifice site and number
• Surrounding skin condition (excoriation, fungal infection)
• Signs of sepsis (fever, tachycardia, hypotension)
• Abdominal examination: Tenderness, mass, peritonism
• Nutritional assessment: BMI, muscle wasting, MUAC

1. Bloods: FBC (leukocytosis, anaemia), U&E (hyponatraemia, hypokalaemia), albumin, pre-albumin (best acute nutritional marker), CRP, magnesium, zinc, phosphate
2. Fistula output: Volume per 24 hrs; pH; electrolyte composition
3. Fistulogram (water-soluble contrast through fistula): Defines tract, origin, length, associated abscess
4. CT abdomen with contrast: Best initial imaging - defines anatomy, identifies abscesses, associated pathology, distal obstruction
5. Fluoroscopy (small bowel follow-through or gastrografin enema): Defines bowel anatomy
6. MRCP: If biliary fistula component
7. Endoscopy: Assess associated IBD, malignancy

---

Management: SNAP Protocol (Stabilize - Nutritional support - Anatomical definition - Procedure)

Phase 1: STABILIZATION (Weeks 1-2)

• IV fluids (correct dehydration - high output fistulas lose large volumes)
• Correct electrolytes: Na+, K+, Mg²+, Zn²+, phosphate
• Blood transfusion if anaemic
• Correct coagulopathy

• IV antibiotics (broad spectrum: piperacillin-tazobactam or meropenem)
• Radiologically guided percutaneous drainage of all collections/abscesses
• Without sepsis control, the fistula will never close
• Sepsis = the #1 cause of death in ECF (accounts for 60-80% of ECF mortality)

• Vacuum-assisted closure (VAC) therapy / wound management systems (Ileostomy bag, SNAP system)
• Skin barrier creams and wafers to prevent excoriation
• Stoma nurse involvement: critical
• Accurate measurement of output volume
• High-output fistulas: Somatostatin analogue (octreotide 100-200 µg SC TDS) - reduces intestinal secretions and fistula output; may improve spontaneous closure rate

Phase 2: NUTRITIONAL SUPPORT (Throughout)

• Total Parenteral Nutrition (TPN) - mainstay of nutrition for high-output ECF:
  • Provides 30-35 kcal/kg/day; protein 1.5-2 g/kg/day
  • Allows bowel rest → reduces fistula output
  • Role of TPN: Maintains nutrition, allows bowel rest, reduces output, promotes spontaneous closure
  • Via dedicated central venous catheter (PICC line or central line)
  • Monitor: Blood glucose, LFTs, line sepsis
• Enteral nutrition (when feasible):
  • Preferred if fistula is distal (output goes through fistula but proximal bowel intact)
  • Elemental/semi-elemental formulas (pre-digested)
  • Nasojejunal tube feeding past the fistula if possible (fistuloclysis)

Phase 3: ANATOMICAL DEFINITION (Week 4-6)

• CT fistulogram, SBFT, fluoroscopy
• Define: Site of fistula, tract length, associated pathology, distal obstruction, foreign body
• Identify FRIENDS criteria (see above) - if any present, spontaneous closure unlikely → plan surgery

• Most fistulas close spontaneously within 4-6 weeks of conservative management
• Closure rate: Low output >80%; High output ~30-50%
• If not closed by 6-8 weeks: Unlikely to close without surgery

Phase 4: PROCEDURE (Elective Surgery - ~3 months from onset)

• Inflammation to subside
• Nutritional optimization (albumin >30 g/L)
• Sepsis fully controlled
• "The hostile abdomen" period to pass (6 weeks minimum)

• Wide laparotomy: Full exploration of abdomen
• Complete adhesiolysis (frozen abdomen)
• Resection of fistula-bearing segment (not simple closure - high recurrence with closure alone)
• Healthy bowel ends re-anastomosed in well-vascularized, tension-free fashion
• Treat underlying cause (Crohn's: strictureplasty/resection; radiation: wide excision)
• Protect anastomosis with proximal defunctioning stoma if contaminated field
• Abdominal wall reconstruction (mesh if needed)

---

Q3. Pathophysiology of Small Intestinal Obstruction ⭐⭐⭐⭐

Causes of SI Obstruction (Classification)

• Gallstone ileus (Bouveret's - gallstone obstructs ileocaecal valve)
• Bezoar
• Foreign body
• Meconium ileus
• Intussusception (in children - physiological lead point; in adults - pathological lead point)

• Stricture (Crohn's disease, TB, radiation, ischaemia)
• Tumors (carcinoma, lymphoma, GIST)
• Congenital atresia/stenosis

• Adhesions (most common cause in adults - prior abdominal surgery)
• External hernia (inguinal, femoral, incisional - incarceration/strangulation)
• Internal hernia
• Volvulus
• Malignant compression

Pathophysiology of SI Obstruction

1. Bowel distension - accumulation of swallowed air + intestinal secretions (7-8 L/day of secretions)
2. Increased peristaltic activity → colic
3. Oedema of bowel wall
4. Nausea and vomiting → fluid and electrolyte loss

• Loss of gastric juice (HCl) + pancreatic secretions (NaHCO3) + bile + intestinal secretions
• Resulting in: Hypovolemia, hyponatraemia, hypokalaemia, metabolic alkalosis or acidosis
• Third-space fluid loss into bowel lumen and peritoneal cavity
• Dehydration → oliguria → prerenal ARF → circulatory collapse

• Distension → increased intraluminal pressure > venous pressure → venous congestion
• Venous congestion → arterial obstruction → ischaemia
• Mucosal barrier breakdown → bacterial translocation (E. coli, Bacteroides, Clostridia)
• Endotoxaemia → septic shock
• Bowel necrosis → perforation → peritonitis (faeculant peritonitis = fatal if untreated)

• Fever (>38°C), tachycardia
• Constant pain (vs. colicky in simple obstruction)
• Peritonism (tenderness, guarding, rigidity)
• Elevated WBC, CRP, lactate
• CT: Thickened bowel wall, mesenteric fat stranding, free fluid, pneumatosis intestinalis

---

Q4 (2018). Neonatal Intestinal Obstruction / Acute IO in Newborn ⭐⭐⭐⭐

General Presentation of Neonatal IO

• Bilious vomiting (most important sign - below the ampulla of Vater)
• Failure to pass meconium (normally within 24-48 hours)
• Abdominal distension (absent in high obstruction)
• Visible peristalsis

Causes by Level

A. DUODENAL OBSTRUCTION

1. Duodenal atresia (most common - 1 in 5000 births):
   • Failure of recanalization of the gut lumen at 6th week of gestation
   • "Double bubble" sign on AXR/antenatal USS: Stomach + duodenum distended; no distal gas
   • Associated with: Down syndrome (30%), annular pancreas, VACTERL, malrotation
   • Surgical: Duodenoduodenostomy (side-to-side) or duodenojejunostomy; diamond-shaped anastomosis
2. Annular pancreas: Pancreatic tissue encircles the 2nd part of duodenum
   • Double bubble on AXR
   • Treatment: Duodenoduodenostomy (bypass, NOT division of pancreas - risks fistula, pancreatitis)
3. Malrotation with volvulus (midgut volvulus): Surgical emergency
   • Failure of normal 270° counterclockwise rotation at 5th-10th week
   • Ladd's bands compress duodenum; entire midgut on narrow SMA pedicle → volvulus
   • Presents as: Bilious vomiting + abdominal pain + bloody stools (ischaemia)
   • AXR: Often normal or "double bubble"; US: SMA vein to left of SMA (reversed)
   • Upper GI contrast: "Corkscrew" duodenum or "Bird's beak" at point of volvulus
   • Emergency surgery (Ladd's procedure): Untwist volvulus (counterclockwise) + divide Ladd's bands + appendicectomy + broaden mesenteric base
   • Do not delay - midgut can infarct within 2 hours

B. JEJUNAL AND ILEAL ATRESIA

• Result of intrauterine mesenteric vascular accident (ischaemia) - distinct from duodenal atresia
• Type I: Mucosal atresia (intact bowel wall)
• Type II: Blind ends connected by fibrous cord
• Type IIIa: Separated blind ends with "V"-shaped mesenteric gap
• Type IIIb: "Apple-peel" / "Christmas tree" atresia - proximal atresia with spiral ileum around narrow mesenteric base (poor prognosis)
• Type IV: Multiple atresias
• AXR: Multiple dilated loops with air-fluid levels; no gas in rectum
• Surgical: Resection of dilated proximal segment + primary anastomosis

C. MECONIUM ILEUS

• 10-15% of neonates with cystic fibrosis present with meconium ileus
• Abnormally viscid meconium (due to absent pancreatic enzymes) obstructs terminal ileum
• AXR: "Soap bubble" appearance in RIF (meconium mixed with air); no air-fluid levels (meconium too viscid)
• Simple meconium ileus: Non-operative: Gastrografin enema (hyperosmolar → draws fluid → loosens meconium); N-acetylcysteine irrigation
• Complicated (perforation, atresia, volvulus): Surgical: Enterotomy + irrigation (Bishop-Koop, Santulli, Mikulicz procedures)
• All cases: Test for CF (sweat chloride test)

D. HIRSCHSPRUNG'S DISEASE (Congenital Aganglionic Megacolon)

• Absence of ganglion cells in Auerbach's (myenteric) + Meissner's (submucosal) plexuses
• Due to failure of neural crest cell migration (cranio-caudal migration arrested)
• Always starts at internal anal sphincter and extends proximally (variable length)
• Short segment (75%): Rectosigmoid; Long segment (25%): Transverse/total colon
• Presentation: Failure to pass meconium >48 hours; abdominal distension; bilious vomiting; explosive passage of stool on PR (squirt sign)
• Diagnosis: Rectal biopsy (suction biopsy in neonates) - GOLD STANDARD: Absence of ganglion cells + hypertrophied nerve fibres + positive acetylcholinesterase staining
• Barium enema: Narrow rectum + dilated proximal colon + transition zone (cone-shaped)
• Anorectal manometry: Absent rectoanal inhibitory reflex (RAIR)
• Treatment:
  • Temporary: Colostomy above aganglionic segment to decompress
  • Definitive: Pull-through procedure (Swenson, Duhamel, Soave operations) - bring ganglionic bowel down to anal canal; performed laparoscopically in most centers

E. ANORECTAL MALFORMATIONS (ARM)

• Imperforate anus (absence of anal opening)
• Classification: Low (below levator ani): Good prognosis; perineal fistula common; primary repair
• High (above levator ani): Associated with rectovesical/rectovaginal fistula; requires colostomy then posterior sagittal anorectoplasty (PSARP / Peña procedure)
• Associated anomalies: VACTERL - Vertebral, Anal, Cardiac, Tracheo-Esophageal fistula, Renal, Limb

F. NECROTIZING ENTEROCOLITIS (NEC)

• Most common GI surgical emergency in neonates (premature infants)
• Pathogenesis: Mucosal ischaemia + bacterial invasion → transmural intestinal necrosis
• Presentation: Abdominal distension + bloody stools + bilious vomiting; feeding intolerance in premature infant
• AXR: Pneumatosis intestinalis (intramural gas - pathognomonic); portal venous gas (advanced); pneumoperitoneum (perforation)
• Bell's staging (I-III): Used to guide management
• Medical (Stage I-IIA): NPO, NG tube, IV antibiotics (ampicillin + gentamicin + metronidazole), TPN
• Surgical (Stage IIB-III, perforation): Peritoneal drain (small premature) or laparotomy + resection of necrotic bowel + stoma formation

---

Q5. Meconium Ileus ⭐⭐⭐

---

Q6 (2021/2018). Carcinoid Tumors / Neuroendocrine Tumors of SI (20 marks) ⭐⭐⭐⭐

Definition and Origin

Epidemiology

• Most common GI neuroendocrine tumor
• Most common site: Appendix (most common overall); terminal ileum (most common to metastasize); rectum (second most common site)
• Rule of 1/3: 1/3 multiple; 1/3 metastasize; 1/3 associated with other primary tumors

Grading (WHO 2019)

Clinical Features

• Intestinal obstruction (tumor + desmoplastic reaction in mesentery)
• Intussusception (as lead point)
• GI bleeding (rarely)
• Mesenteric ischemia (desmoplastic reaction kinks/constricts SMA branches)

• Normally serotonin from portal drainage is inactivated in the liver
• With liver metastases, serotonin/other amines directly enter systemic circulation
• Classic triad: Flushing + Diarrhea + Right-sided cardiac valvular disease (carcinoid heart disease - tricuspid regurgitation + pulmonary stenosis = TRICUSPID AND PULMONARY)
• Other features: Bronchospasm (wheeze), pellagra-like skin changes, telangiectasia, hypotension
• Precipitants of flush: Food, alcohol, stress, catecholamines

• Prevention: Preoperative octreotide (somatostatin analogue) - MANDATORY

Investigations

1. 24-hr urine 5-HIAA (5-hydroxyindoleacetic acid): Metabolite of serotonin; >25 mg/day = positive (sensitivity 73%; specificity 100%); avoid serotonin-rich foods (bananas, avocado, tomatoes) for 48 hours before test
2. Serum Chromogranin A (CgA): Best serum marker; elevated in >80%; monitors treatment response
3. CT/MRI abdomen: Liver metastases; mesenteric fibrosis ("stellate" mesenteric mass); bowel wall thickening
4. Octreotide scan (Somatostatin Receptor Scintigraphy - SRS / Octreoscan): Detects somatostatin receptor-positive tumors; best for staging and detecting occult metastases
5. Ga-68 DOTATATE PET-CT: More sensitive than Octreoscan; now preferred for staging
6. Echocardiography: Assess carcinoid heart disease
7. Colonoscopy/endoscopy: For accessible rectal/appendiceal tumors

Management

Localized Disease (Surgical):

• Appendiceal carcinoid:
  • <2 cm: Simple appendicectomy (curative; <2% metastasis rate)

  • 2 cm or at appendiceal base/mesoappendix invasion: Right hemicolectomy + D2 lymph node clearance

• Small bowel (ileal) carcinoid:
  • Resection of bowel + wide mesenteric clearance (desmoplastic mesentery)
  • Include regional lymph nodes in resection
  • Multi-focal in 25-30%: May require extended resection
• Rectal carcinoid:
  • <1 cm, T1: Local excision (transanal endoscopic microsurgery/TEM)

  • 2 cm: Anterior resection or APE

Metastatic Disease:

1. Somatostatin analogues (Octreotide LAR or Lanreotide): First-line for symptomatic control; antiproliferative effect (PROMID trial: Octreotide LAR significantly prolongs time-to-progression)
2. Hepatic debulking/ablation: If >90% liver disease can be removed → reduces carcinoid syndrome; RFA, microwave ablation
3. PRRT (Peptide Receptor Radionuclide Therapy) with Lutetium-177 (Lu-177 DOTATATE): For progressive, somatostatin receptor-positive NETs (NETTER-1 trial: Improved PFS); major advance
4. Chemotherapy: For G3/NEC: Etoposide + cisplatin; for G1/G2: Streptozocin + 5-FU (pancreatic NETs better response than SI NETs)
5. mTOR inhibitors: Everolimus
6. Liver transplantation: Highly selected patients with non-resectable liver-only disease
7. Carcinoid syndrome control: Octreotide; carcinoid crisis - IV octreotide (1 mg bolus)

---

Q7 (2023). Crohn's Disease (10 marks) - Intestinal + Extraintestinal Manifestations ⭐⭐⭐⭐⭐

Definition

Pathology

• Transmural inflammation (distinguishes from UC which is mucosal only)
• Discontinuous/skip lesions with normal bowel between affected segments
• Non-caseating granulomas (50-60%)
• Cobblestone mucosa; rose-thorn ulcers; fissuring ulcers penetrating to muscularis
• Creeping fat; string sign on barium (narrowed lumen)
• Distribution: Terminal ileum + caecum (40% - ileocolic/ileocaecal type); ileum only (30%); colon only (20%); upper GI (rare); perianal disease alone (rare)

Clinical Features - Intestinal

• Chronic/intermittent RIF pain (mimics appendicitis)
• Diarrhea (non-bloody, or bloody in colonic CD)
• Weight loss, malnutrition
• Fever (low grade)
• Palpable RIF mass (inflammatory mass)
• Fatigue

1. Strictures → intestinal obstruction (string sign on barium)
2. Fistulae: Entero-enteric, enterovesical (fecaluria, pneumaturia), enterovaginal, enterocutaneous, perianal
3. Abscess: Intra-abdominal or perianal
4. Perforation (rare - more common in UC; may be contained as abscess)
5. Haemorrhage (rare)
6. Malignancy: Slightly increased colorectal and small bowel cancer risk (less than UC)
7. Perianal disease: Fissures, fistulae (complex, multiple), abscesses, skin tags - "watering can perineum"

Extraintestinal Manifestations (EIMs)

• Peripheral arthropathy (most common EIM - 30%): Large joint monoarthritis, parallels gut activity
• Erythema nodosum: Tender red nodules on extensor surfaces of legs
• Episcleritis: Eye inflammation
• Aphthous mouth ulcers

• Ankylosing spondylitis / sacroiliitis: HLA-B27 associated
• Pyoderma gangrenosum: Ulcerating skin lesion; often lower limb
• Uveitis/Iritis
• Primary Sclerosing Cholangitis (PSC): More common in UC than CD

• Anaemia (B12, folate, iron deficiency - multiple causes)
• Osteoporosis (steroid use + malabsorption)
• Growth retardation (children)
• Renal calculi (oxalate stones due to fat malabsorption → unbound oxalate absorbed)
• Gallstones (bile salt malabsorption from terminal ileum)
• Amyloidosis (secondary - long-standing inflammation)

Investigations

1. Blood: FBC (anaemia), CRP, ESR (active disease), albumin, B12, folate, iron studies
2. Stool: Fecal calprotectin (elevated in active inflammation - distinguishes from IBS); MC&S; C. diff
3. Colonoscopy + ileoscopy + biopsy: Gold standard; biopsy for granulomas
4. MRI enterography (MRE): Investigation of choice for small bowel CD extent; no radiation; identifies strictures, fistulae, abscesses
5. CT abdomen: Complications (abscesses, perforation); disease extent
6. Capsule endoscopy: Small bowel mucosal disease (only if no stricture)
7. Barium meal/SBFT: String sign of Kantor in terminal ileum stricture; rose thorn ulcers

Management

• Induction of remission (acute flare):
  • Mild-moderate: 5-ASA (limited efficacy in CD), budesonide (ileal/right colon CD), prednisolone
  • Severe: IV hydrocortisone; IV infliximab
• Maintenance of remission:
  • Azathioprine/6-MP (thiopurines): First-line steroid-sparing
  • Methotrexate: Alternative
  • Anti-TNF biologics: Infliximab, adalimumab - for steroid-refractory or fistulating CD
  • Anti-integrins: Vedolizumab (gut-selective)
  • Anti-IL-12/23: Ustekinumab
• Perianal CD: Setons for complex fistulae + infliximab (combination highly effective)

• Failed medical therapy
• Obstruction (stricture)
• Fistula/abscess not responding to conservative treatment
• Perforation, haemorrhage
• Cancer (or dysplasia on surveillance)

• Bowel-conserving surgery: Minimal resection; strictureplasty rather than resection where possible (prevents short bowel syndrome)
• Strictureplasty: Heineke-Mikulicz (for strictures <10 cm); Finney (10-25 cm); Michelassi (>25 cm); longitudinal incision along anti-mesenteric border, closed transversely
• Resection + anastomosis: When stricture too long or multiple; always with disease-free margins (2 cm is adequate - no benefit from wide margins)
• Perianal disease: Seton drainage; fistulotomy for simple fistulae; colostomy for severe perianal disease

---

Q8. Short Bowel Syndrome ⭐⭐⭐⭐

Definition

Causes (Adults)

1. Acute mesenteric ischemia (most common single-event cause)
2. Crohn's disease (most common cause of cumulative/repeated resections)
3. Malignancy with extensive resection
4. Radiation enteritis
5. Midgut volvulus
6. Trauma

Critical Lengths

Physiological Effects

• Fat malabsorption → steatorrhoea; fat-soluble vitamin (A, D, E, K) deficiency
• Protein malabsorption → hypoalbuminaemia
• Carbohydrate malabsorption → osmotic diarrhea

• Bile salt malabsorption → fat malabsorption + gallstone formation; bile acid diarrhea
• Vitamin B12 malabsorption → megaloblastic anaemia (intrinsic factor-B12 complex absorbed only in terminal ileum)
• Fat-soluble vitamins (A, D, E, K) deficiency

• High-output stoma or diarrhea → dehydration, hyponatraemia, hypomagnesaemia
• Massive fluid and electrolyte replacement required

• Reduced GIP/GLP-2 after gut resection → gastrin hypersecretion → acid hypersecretion → peptic ulceration; inactivates pancreatic enzymes; worsens malabsorption
• Treat with PPI

Intestinal Adaptation

• Structural: Increased villous height, crypt depth, bowel diameter, length
• Functional: Increased absorptive capacity per unit length
• Time: 1-2 years
• Stimulated by: Enteral feeding (nutrients in lumen), GLP-2, growth factors, trophic hormones

Management

• IV fluids and electrolyte replacement
• TPN to maintain nutrition (life-sustaining in early phase)
• Octreotide/somatostatin: Reduces secretions, diarrhea
• High-dose PPI: Reduces hypergastrinemia and acid hypersecretion
• H2 blockers: Adjunct

• Gradual introduction of enteral feeding (triggers adaptation)
• GLP-2 analogue: Teduglutide (synthetic GLP-2) - promotes intestinal adaptation; reduces TPN requirements; approved by FDA/EMA for adults with SBS
• Small frequent oral feeds; elemental/semi-elemental formulas initially
• High-sodium oral rehydration solution
• Gradual reduction of TPN as enteral tolerance increases

• Some achieve enteral autonomy (off TPN)
• Others require long-term home TPN (life-long)
• Monitor: Nutritional markers, liver function (TPN-associated liver disease), line infections

1. STEP procedure (Serial Transverse Enteroplasty): Serially stapling dilated bowel in V-shapes alternating sides → decreases width + increases length; currently preferred
2. Bianchi procedure (Intestinal Lengthening and Tailoring - LILT): Longitudinal split of dilated bowel into two segments each with own mesenteric blood supply; technically demanding
3. Reversed intestinal segment: Slows transit
4. Small bowel transplantation: For patients with life-threatening TPN complications (line sepsis, liver failure); 5-year survival ~50%; requires immunosuppression; high rejection rate

---

Q11. Surgical Complications of Enteric Fever (Typhoid) ⭐⭐⭐⭐

Background

Intestinal Complications

1. Intestinal Perforation (Most Dangerous)

• Incidence: 1-3% of hospitalized cases; mortality 10-25%
• Timing: Most common in 3rd week of illness
• Site: Terminal ileum (Peyer's patches)
• Pathogenesis: Ulceration of Peyer's patches → necrosis → perforation (perforations characteristically small, oval, on antimesenteric border of ileum)
• Clinical features: Sudden worsening of abdominal pain; from periumbilical/RIF to generalized peritonitis; fever may paradoxically decrease; rigid abdomen
• Investigations: Erect AXR - free gas under diaphragm (in only ~50%; small perforations may seal with omentum); CT: Free gas, fluid, peritonitis; blood cultures
• Management:
  • Resuscitation: IV fluids, NGT, urinary catheter
  • IV antibiotics: Ceftriaxone (3rd generation cephalosporin) as drug of choice; or fluoroquinolone (ciprofloxacin); cover anaerobes with metronidazole
  • Emergency surgery:
    • Simple closure + Graham patch (if single, clean perforation)
    • Resection + primary anastomosis (if multiple perforations, viable bowel, non-contaminated)
    • Resection + end ileostomy (if grossly contaminated, multiple perforations, unhealthy bowel - most common and safest in resource-limited settings)
  • Continue antibiotics 10-14 days post-op

2. Intestinal Haemorrhage

• Incidence: 10-20% (occult); ~2% massive (requiring transfusion/intervention)
• Timing: 2nd-3rd week
• Pathogenesis: Ulceration of Peyer's patches → mucosal blood vessel erosion
• Management: Blood transfusion; continue anti-typhoid antibiotics; colonoscopy if localised; surgery rarely needed (oversewing of bleeding ulcer)
• Mortality from massive haemorrhage: 10-25%

3. Typhoid Cholecystitis

• Salmonella can colonize the gallbladder (bile provides ideal growth medium) → acute cholecystitis
• Gallbladder is also the reservoir for carrier state
• Chronic carriers: S. typhi persists in GB (especially in patients with gallstones)
• Treatment of carrier state: Prolonged ciprofloxacin; cholecystectomy in carriers with gallstones (most effective to eliminate carriage)

4. Hepatic Abscess (Rare)

• Bacteremia → seeding of liver
• Management: IV antibiotics + percutaneous drainage

Extra-intestinal Complications (for completeness)

• Myocarditis (bradycardia relative to fever - "Faget's sign")
• Encephalopathy, meningitis
• Bone marrow depression (thrombocytopaenia → DIC)
• Pneumonia
• Splenic rupture (rarely)

---

Q12. Toxic Megacolon - Management ⭐⭐⭐

Definition

Pathophysiology

• Severe transmural inflammation → paralysis of colonic muscularis → loss of haustral markings → dilatation
• Risk of: Perforation (mortality >40%), massive haemorrhage, septic shock

Diagnosis

• Clinical + AXR: Transverse colon diameter >6 cm with thumbprinting; loss of haustral markings
• Truelove and Witts criteria of severe UC: ≥6 stools/day + at least one: Fever >37.8°C, Pulse >90/min, Hb <105 g/L, ESR >30 mm/hr
• Suspect toxic megacolon if colitis patient develops: Abdominal distension + abdominal tenderness + systemic toxicity

Management

1. Resuscitation: IV fluids, blood transfusion, correct electrolytes (K+, Mg²+)
2. IV hydrocortisone 400 mg/day (or methylprednisolone): First-line
3. IV antibiotics: Cover enteric organisms + anaerobes (ciprofloxacin + metronidazole or piperacillin-tazobactam)
4. Stop all gut motility agents: Opioids, anticholinergics, antidiarrheals - can worsen dilatation
5. NGT decompression: NG suction
6. Positional changes: Roll patient every 2-4 hours; prone position may help gas redistribution
7. Rectal tube: Decompression
8. DVT prophylaxis: Heparin (high VTE risk in UC)
9. Daily AXR and clinical assessment

• Infliximab (5 mg/kg IV): If IV steroids fail (anti-TNF rescue therapy)
• Ciclosporin (continuous IV infusion): Alternative rescue
• Both have ~50% response rate in acute severe UC

• Perforation (absolute emergency)
• Haemorrhage not controlled medically
• Failure to improve on maximum medical therapy (72 hrs)
• Clinical deterioration at any point

• Subtotal colectomy + end ileostomy (Hartmann's procedure for colon) - safest; preserves rectal stump for later reconstruction; allows histology; definitive curative option later
• NOT restorative proctocolectomy in emergency (high mortality, anastomotic leak risk in sick patient)
• Total proctocolectomy + ileal pouch-anal anastomosis (IPAA): Elective, after recovery

---

Q13 (2018/2021). Etiopathology, CF, Ix & Management of Ileocaecal TB ⭐⭐⭐⭐⭐

Etiopathology

1. Primary intestinal (most common): Swallowed infected sputum from pulmonary TB → Peyer's patches in ileocaecal region
2. Haematogenous spread from primary pulmonary focus
3. Direct spread from adjacent organs

1. Ulcerative (most common, 60%): Transverse ulcers on antimesenteric border (perpendicular to bowel axis - differentiates from typhoid's longitudinal ulcers and Crohn's longitudinal); may perforate/bleed
2. Hypertrophic (25%): Fibrosis and hypertrophy; mass lesion in RIF; may obstruct; mimics carcinoma
3. Ulcerohypertrophic (mixed): 15%
4. Peritoneal TB: Dry (encysted, adhesive) or wet (exudative ascites)

Clinical Features

• Chronic diarrhea (may alternate with constipation in hypertrophic)
• Weight loss, anorexia, night sweats, low-grade fever (systemic TB features)
• RIF pain (often colicky)
• Palpable RIF mass (doughy, non-tender - hypertrophic type)
• Ascites (peritoneal TB - "dough belly")
• Complications: Obstruction (most common surgical complication), fistula, perforation (rare), haemorrhage (rare), malabsorption

Investigations

1. Blood: FBC (anaemia, lymphocytosis), raised ESR/CRP, low albumin; Mantoux test (positive in >80% but not diagnostic alone)
2. IGRA (Interferon Gamma Release Assay - QuantiFERON-TB Gold): Highly specific; not affected by BCG vaccination
3. CXR: Active or old pulmonary TB (50% have pulmonary lesion)
4. Colonoscopy + biopsy (KEY investigation):
   • Findings: Ulcers (transverse), patulous ileocaecal valve (gaping - differentiates from Crohn's which has a fixed/narrowed ICV), cobblestoning (also in Crohn's), caecal involvement
   • Biopsy: Caseating granulomas; AFB; PCR for M. tuberculosis (rapid, high specificity)
5. CT abdomen: Thickened ileocaecal region; enlarged necrotic mesenteric lymph nodes (with central low attenuation due to caseation - CHARACTERISTIC); ascites; "Club sandwich sign" in peritoneal TB
6. CECT chest + abdomen: Full staging
7. Laparoscopy: For peritoneal TB - peritoneal nodules; ascites sampling
8. Sputum AFB + culture: If pulmonary TB suspected
9. Barium enema/SBFT: "Stierlin's sign" (rapid emptying of barium from ileocaecal region due to irritability)

Differentiating Ileocaecal TB from Crohn's Disease

Management

• Anti-tuberculous therapy (ATT): Standard regimen
  • Phase 1 (Intensive, 2 months): HRZE - Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) daily
  • Phase 2 (Continuation, 4-7 months): HR - Isoniazid + Rifampicin (total 6-9 months for intestinal TB; some recommend 9-12 months)
• Add pyridoxine (B6) with isoniazid (prevent peripheral neuropathy)
• Monitor: LFTs (drug hepatotoxicity), visual acuity (ethambutol)
• Most patients respond to medical treatment; obstruction may improve

1. Intestinal obstruction not responding to ATT (acute: emergency; subacute: elective after ATT)
2. Perforation (peritonitis) - emergency
3. Haemorrhage not controlled
4. Failure to respond to ATT (diagnostic uncertainty - resection for histology)
5. Fistula formation
6. Palpable mass causing obstruction
7. Malignancy not excluded (RIF mass)

• Right hemicolectomy (most common): For hypertrophic or ulcerohypertrophic type; palpable mass; malignancy cannot be excluded
• Limited resection + anastomosis: For localized ileal disease
• Defunctioning ileostomy: For emergency (perforation with peritonitis); unhealthy bowel; delayed anastomosis
• Strictureplasty: Only for short fibrous strictures (controversial in TB due to active disease at site)
• Always continue ATT perioperatively and postoperatively (minimum 6-9 months total)

---

Q (2016/2017). CF, Ix & Mx of Ulcerative Colitis + Pathology (20 marks) ⭐⭐⭐⭐⭐

Pathology

• Mucosal and submucosal inflammation only (unlike Crohn's which is transmural)
• Continuous inflammation starting from rectum (always involved) extending proximally
• Crypt abscesses: Polymorphs fill crypts of Lieberkühn
• Pseudopolyps: Islands of inflamed mucosa surrounded by ulceration
• Goblet cell depletion; surface epithelial erosions
• No granulomas (distinguishes from Crohn's)
• Distribution: Proctitis (40%), left-sided colitis (35%), pancolitis (25%)

Clinical Features

• Bloody diarrhea with mucus (hallmark - blood always present; distinguishes from Crohn's)
• Rectal urgency, tenesmus
• Crampy lower abdominal pain (relieved by defecation)
• Systemic: Fever, malaise, weight loss (in moderate-severe disease)

• Mild: <4 stools/day, no systemic features, minimal blood
• Moderate: 4-6 stools/day, minimal systemic upset
• Severe (Acute Severe UC - ASC): >6 bloody stools/day + ANY ONE of: Fever >37.8°C, Pulse >90 bpm, Hb <105 g/L, ESR >30 mm/hr

Investigations

1. Stool culture + MC&S: Exclude infective colitis (C. difficile, Salmonella, Shigella, Campylobacter)
2. FBC: Anaemia; leukocytosis; thrombocytosis
3. ESR, CRP: Active disease
4. AXR: Mucosal oedema; thumbprinting; colonic dilatation (toxic megacolon)
5. Flexible sigmoidoscopy + biopsy: Even in acute disease (limited, unprepared); confirms diagnosis; assesses extent; grades severity; crypt abscesses on biopsy
6. Colonoscopy: When safe (NOT in acute severe); full extent; dysplasia surveillance
7. CT abdomen: Complications; wall thickening; toxic megacolon; free perforation

Management

• Mesalazine (oral ± rectal) - first-line for mild-moderate UC
• Mechanism: Local anti-inflammatory (inhibit prostaglandin synthesis, NF-κB, etc.) at colonic mucosa
• Rectal mesalazine + oral combined: Better for left-sided disease
• Maintenance: Indefinite (reduces cancer risk + maintains remission)

• Oral prednisolone: For moderate flares
• IV hydrocortisone 400 mg/day: For acute severe UC
• Budesonide (MMX): For mild-moderate disease; less systemic effects
• Not for maintenance (side effects)

• Steroid-sparing agents; maintenance of remission; combination with infliximab reduces immunogenicity

• Infliximab (anti-TNF): For moderate-severe UC, steroid-refractory; IV infusion; rescue therapy in ASC
• Adalimumab: Anti-TNF; subcutaneous
• Vedolizumab (anti-α4β7 integrin): Gut-selective; good safety profile; for moderate-severe UC
• Tofacitinib (JAK inhibitor): Oral; for moderate-severe UC; rapid onset
• Ustekinumab (anti-IL-12/23): Approved for UC

• Emergency: Toxic megacolon, perforation, massive haemorrhage, fulminant colitis not responding to 72 hrs intensive medical therapy
• Elective: Chronic refractory disease; cancer or high-grade dysplasia on surveillance; growth failure in children; intolerable drug side effects

• Gold standard: Restorative proctocolectomy + Ileal pouch-anal anastomosis (IPAA / J-pouch):
  • Remove entire colon + rectum
  • Create ileal J-pouch (or S/W-pouch) and anastomose to anal canal
  • Typically staged: 1st - colectomy + end ileostomy; 2nd - pouch creation + loop ileostomy; 3rd - ileostomy reversal
  • Functional outcome: 4-8 stools/day; ~85% satisfied
  • Complications: Pouchitis (30%), anastomotic leak, small bowel obstruction
• Proctocolectomy + end ileostomy (Brooke ileostomy): When pouch contraindicated (incontinence, distal rectal cancer)
• Emergency: Subtotal colectomy + end ileostomy (leave rectal stump) - then delayed IPAA

• Pancolitis for >10 years: ~0.5-1% per year cancer risk
• Surveillance colonoscopy: Annually after 8-10 years of pancolitis; chromo-endoscopy preferred
• High-grade dysplasia: Prophylactic colectomy

---

Q (2018-20). Types, CF & Mx of Mesenteric Vascular Ischaemia ⭐⭐⭐⭐⭐

Classification

Clinical Features

• Classic presentation: Severe, sudden-onset periumbilical pain OUT OF PROPORTION to physical examination (gut pain without peritonism initially)
• Nausea, vomiting, diarrhoea (often bloody)
• Initial absence of peritonism (gut ischaemia pre-infarction)
• Later (infarction): Fever, sepsis, peritonism, absent bowel sounds, shock
• History: Atrial fibrillation (source of embolus); atherosclerosis; recent MI; hypercoagulable state

• Postprandial pain (30-60 min after eating, lasts 1-2 hrs): "Food fear"
• Significant weight loss (avoid eating due to pain)
• Multiple auscultatory bruits over abdomen
• Elderly atherosclerotic patient

Investigations

1. CT angiography (CTA) abdomen + pelvis - investigation of choice: SMA occlusion/embolus, thickened bowel wall, pneumatosis intestinalis, free gas, ascites
2. Blood: Lactate (elevated >2 mEq/L in ischaemia; >4 = severe); WBC, CRP (elevated late)
3. AXR: Non-specific early; "thumbprinting" (submucosal oedema); late pneumatosis, portal venous gas
4. Urgent echocardiogram/cardiac monitor: Source of embolus
5. Formal mesenteric angiography: If endovascular treatment planned

Management

• IV fluids, IV antibiotics (broad spectrum - cover enteric organisms)
• Anticoagulation: IV heparin infusion (for all types - prevents propagation)
• Correct cardiac failure, arrythmias (AF cardioversion/control)

Acute Arterial Occlusion (Embolism):

• Catheter-directed thrombolysis (t-PA via SMA catheter) - endovascular
• Mechanical thrombectomy (aspiration via catheter)

• Emergency laparotomy:
  1. Embolectomy (Fogarty catheter via SMA exposure at root of mesentery)
  2. Assess bowel viability: Color, peristalsis, Doppler, fluorescein under UV light, on-table angiography
  3. Resect non-viable bowel
  4. Second-look laparotomy at 24-36 hours (planned re-look for questionable bowel viability)
  5. Anastomosis vs. stoma depending on degree of contamination and viability

• Bypass surgery: SMA bypass (aortomesenteric, iliac-mesenteric using vein or PTFE graft)
• Or endovascular stenting if suitable anatomy

• Treat underlying cause (cardiogenic shock, sepsis, hypovolaemia)
• Intra-arterial papaverine infusion via SMA catheter (vasodilator - mainstay of treatment)
• IV glucagon; avoid vasoconstrictors (vasopressin, noradrenaline)
• Surgery only for bowel necrosis

• IV anticoagulation (heparin → warfarin/LMWH) for 3-6 months
• Investigate for underlying thrombophilia (Factor V Leiden, protein C/S deficiency, JAK2 mutation)
• Surgery only for bowel necrosis

• Endovascular: Percutaneous transluminal angioplasty (PTA) + stenting of SMA/CA: First-line (less morbid than surgery)
• Open bypass surgery: Aortomesenteric bypass (superior long-term patency); used if endovascular fails or unfavourable anatomy
• Risk factor modification: Statins, antiplatelet, smoking cessation

---

Q15 & Q(2016/2026). Management of Complications of Ileostomy / High-Output Ileostomy ⭐⭐⭐⭐

Complications of Ileostomy

1. Ischaemia/necrosis: Dark/black stoma; requires urgent refashioning or colostomy
2. Retraction: Stoma pulls back below skin surface; appliance leakage; requires refashioning
3. Obstruction (paralytic ileus or adhesion): Conservative first; laparotomy if unresolved
4. High output (see below)
5. Wound infection/dehiscence

1. Prolapse: Telescoping of bowel through stoma; manual reduction; elective refashioning
2. Stenosis/stricture: Difficult appliance fitting; faecal impaction; dilation or refashioning
3. Parastomal hernia: Most common late complication; bowel herniates through abdominal wall alongside stoma; management: Appliance modification → mesh repair (parastomal mesh)
4. Skin excoriation/dermatitis: From alkaline small bowel effluent contact; barrier creams, correct appliance fitting
5. Peristomal varices: In portal hypertension; bleeding
6. Pyoderma gangrenosum: In IBD patients
7. Fistula through stoma site

High-Output Ileostomy (HOI)

• Short bowel (extensive resection)
• Proximal loop ileostomy (less bowel available for absorption)
• High-dose steroids
• Enteric infection (C. diff, other)
• Obstruction (partial, causing overflow)
• Crohn's recurrence at stoma
• Medications (laxatives, pro-kinetics)

• Dehydration + sodium depletion (isotonic loss)
• Hypomagnesaemia (most common electrolyte deficiency - difficult to correct orally)
• Hypokalaemia, hyponatraemia
• Metabolic acidosis (loss of bicarbonate)
• Malnutrition
• Renal impairment (prerenal)
• Vitamin B12 deficiency (if ileum resected)

• No water/tea/juice (hypotonic fluid drives sodium out)
• Restrict fluid intake to <500-1000 mL/day

• Glucose 20 g + NaCl 3.5 g + NaHCO3 2.5 g + KCl 1.5 g in 1 litre water
• Sodium concentration ~90 mmol/L - drives active glucose-sodium cotransport absorption

• Loperamide (4 mg QID - reduce transit): Up to 16-32 mg/day in HOI
• Codeine phosphate: Anti-motility
• Omeprazole/PPI: High dose (reduces gastric secretions - often hypersecretion in SBS)
• Octreotide/somatostatin: Reduces all GI secretions; for refractory HOI

• IV saline (0.9% NaCl)
• IV/IM magnesium (oral poorly absorbed in HOI)
• IV potassium

• TPN if enteral intake inadequate
• Oral diet: High-carbohydrate, high-protein, low-fat, low-fibre; small frequent meals

---

Q16. Surgical Anatomy of Duodenum ⭐⭐⭐⭐

Overview

Parts and Relations

• Runs upwards and posteriorly from pylorus
• First 2.5 cm: Intraperitoneal (lesser sac above, greater sac below)
• Relations: Common bile duct (posteriorly + laterally), gastroduodenal artery (posteriorly), portal vein (posteriorly), gallbladder (anteriorly)
• DU (duodenal ulcers): Occur on anterior wall of D1 → perforation (peritonitis); posterior wall → bleed from GDA

• Descends along right side of vertebral column (L1-L3)
• Firmly retroperitoneal (Kocher's manoeuvre detaches)
• Ampulla of Vater (major duodenal papilla): Opening of CBD + pancreatic duct (Wirsung); on posteromedial wall of D2, ~8 cm from pylorus
• Minor papilla: Opening of accessory pancreatic duct (Santorini); 2 cm above major papilla
• Relations: Head of pancreas (medially), right kidney, right ureter, IVC

• Crosses midline, level of L3
• Crossed anteriorly by: Root of mesentery + SMA + SMV (crossing of SMA over D3 is the anatomical basis of SMA syndrome)
• Relations: IVC, aorta, right ureter (all posterior)

• Ascends to left of L2
• Ends at duodenojejunal flexure (DJ junction) = ligament of Treitz (suspensory muscle of duodenum; fibromuscular band from right crus of diaphragm to DJ flexure)
• DJ flexure: Landmark for upper vs. lower GI bleeding and starting point of jejunum measurement

Blood Supply

• Gastroduodenal artery (GDA): From common hepatic artery → divides into: Superior pancreaticoduodenal artery (SPDA) + right gastroepiploic artery
• Inferior pancreaticoduodenal artery (IPDA): From SMA
• SPDA + IPDA form anterior and posterior pancreaticoduodenal arcades

Surgical Significance

1. Kocher's manoeuvre: Mobilization of D2 (incise lateral peritoneum) → exposes IVC, aorta, SMA, CBD → required for: Pancreaticoduodenectomy, ERCP-related surgery, exposure of CBD
2. DU perforation: Site of anterior D1 perforation → peritonitis; posterior → bleeds from GDA (requires suture-ligation of GDA branches through defect or through gastrotomy)
3. SMA syndrome: D3 compressed between SMA and aorta (mesenteric angle <25°)
4. Iatrogenic injury: During lap cholecystectomy, colectomy, nephrectomy

---

Q (Q2017). Fluid & Nutritional Consequences of Intestinal Resection ⭐⭐⭐⭐

Depends on: Site, extent, condition of remaining bowel, presence of ICV

• Iron, folate, calcium, phosphorus, fat-soluble vitamins: Primarily absorbed in duodenum/proximal jejunum
• Impaired: Iron deficiency anaemia; folate deficiency

• Most macronutrients and minerals absorbed here
• Early: Massive fluid + electrolyte loss (high jejunal secretion rate)
• Ileum adapts and takes over; usually tolerates well if ileum intact

• Bile salt malabsorption (<100 cm resected): Excess bile salts reach colon → secretory diarrhea ("Bile salt diarrhea"); treat with cholestyramine
• Bile salt malabsorption (>100 cm resected): Depleted bile salt pool → fat malabsorption → steatorrhoea; fat-soluble vitamin deficiency; gallstones (reduced enterohepatic circulation)
• Vitamin B12 malabsorption (terminal ileum): IM B12 injections for life
• Hyperoxaluria (unbound oxalate absorbed) → calcium oxalate renal stones
• If >50% small bowel: Short bowel syndrome (see Q8)

• Loss of "brake" → rapid transit → malabsorption
• Bacterial overgrowth (colonic bacteria reflux into ileum)
• Worsens malabsorption, B12 deficiency, deconjugation of bile salts

---

Q14. Surgical Anatomy of SMA + SMA Syndrome ⭐⭐⭐

---

Priority Study Guide for SMALL INTESTINE

THE BIG 6 (Must Master - Appear Every Year):

• Memorize: SNAP protocol + FRIENDS mnemonic
• Role of TPN: Bowel rest + nutrition + reduce output
• Key point: Sepsis control is the #1 priority before anything else

• Key differentials from Crohn's: Caseating granulomas, patulous ICV, transverse ulcers, positive Mantoux/IGRA, AFB+
• CT feature: Necrotic mesenteric LN with central caseation
• ATT: 2 months HRZE + 4-7 months HR

• Truelove & Witts severity (>6 bloody stools + fever/tachycardia/low Hb/raised ESR = severe)
• Surgical gold standard: Restorative proctocolectomy + IPAA (J-pouch)
• Emergency: Subtotal colectomy + end ileostomy first

• "Pain out of proportion to examination" = classic AMI
• SMA embolism (50%) + SMA thrombosis (25%) + NOMI (20%) + MVT (5%)
• CT angiography = investigation of choice; Second-look laparotomy = essential

• Critical lengths: <100 cm (no colon) or <60 cm (with colon) = permanent TPN
• Treatment: Teduglutide (GLP-2 analogue) - reduces TPN requirements
• Surgical: STEP procedure (Serial Transverse Enteroplasty)

• Double bubble = duodenal atresia (Down syndrome); apple-peel = Type IIIb jejunal atresia
• Malrotation with volvulus = Surgical emergency; Ladd's procedure
• Hirschsprung's: Diagnosis by suction rectal biopsy; absent ganglion cells; RAIR absent

High-Yield Quick Facts:

• Carcinoid: 24-hr urine 5-HIAA + Ga-68 DOTATATE PET-CT; Lutetium-177 PRRT for metastatic
• Crohn's: Skip lesions, transmural, non-caseating granulomas, perianal disease; strictureplasty (Heineke-Mikulicz)
• HOI: Restrict hypotonic fluids; ORS (Na 90 mmol/L); loperamide; octreotide
• Typhoid perforation: Small oval perforations on antimesenteric border of terminal ileum; resection + end ileostomy safest

---

Exam Weightage Guide

---

Q2 (2016). Sigmoid Volvulus ⭐⭐⭐⭐⭐

Definition

Predisposing Factors

• Long, redundant sigmoid colon with a narrow mesenteric base (anatomical predisposition)
• High-residue (high-fibre) diet - elongates sigmoid
• Chronic constipation / dysmotility
• Advancing age (7th decade peak); 2:1 male predominance
• Institutionalized/psychiatric patients (psychotropic drugs → dysmotility)
• Pregnancy (uterine mass displaces sigmoid)
• Neurological disorders (Parkinson's, Chagas disease)
• More common in Africa, Asia, Eastern Europe (dietary factors); most common cause of LBO in indigenous black African population

Types of Presentation

1. Fulminant (acute): Sudden onset, severe pain, rapid deterioration, early ischaemia
2. Indolent (subacute): Slow, progressive, insidious; less pain; late vomiting; more common

Clinical Features

• Severe, crampy, progressive abdominal pain
• Massive abdominal distension (disproportionate - "tympanic giant abdomen")
• Absolute constipation (obstipation - no flatus or stool)
• Nausea and vomiting (later)
• Features of intestinal obstruction
• With ischaemia/gangrene: Fever, tachycardia, peritonism, septic shock

Investigations

1. Plain AXR (Erect + Supine) - First and most important:
   • "Coffee bean sign" or "Bent inner tube sign" or "Omega loop sign": Massively dilated sigmoid loop rising up from the pelvis, pointing towards the RUQ (right hypochondrium); visible in 60-75%
   • Absence of rectal gas
   • Distended colon proximal to volvulus
2. CT Abdomen - if AXR non-diagnostic or to plan treatment:
   • "Whirl sign": Twisted mesentery (pathognomonic of volvulus)
   • "Beak sign": Narrowing at point of torsion
   • Paucity of rectal gas; near 100% accuracy
   • Assesses ischaemia (wall thickening, pneumatosis, free fluid)
3. Water-soluble contrast enema (Gastrografin): "Bird beak" / "Ace of spades" deformity at point of torsion
4. Bloods: FBC (leukocytosis if ischaemia), U&E, lactate (elevated in ischaemia)

Management

Initial Decision: Ischaemia/Peritonism? → Dictates approach

---

• Flexible sigmoidoscopy (preferred; allows mucosal inspection) or rigid proctoscopy
• Gentle passage through the torsed segment with air insufflation
• "Pinwheel appearance" seen at point of torsion as scope enters
• After passage: Massive rush of flatus and stool (confirms detorsion)
• Leave soft red-rubber flatus tube in situ for 24-48 hours (decompression + prevents immediate recurrence)
• Success rate: 55-94%
• After detorsion: Inspect mucosa - if viable (pink) → stabilize and plan elective surgery; if ischaemia → emergency surgery

• Recurrence after endoscopic detorsion alone: 85-90% (without surgery)
• Mortality of recurrent episode: 1 in 3 (33%)
• Gold standard: Sigmoid colectomy + primary anastomosis (elective, after bowel prep, optimised nutrition)
• Laparoscopic approach preferred in stable patients
• Alternatives (historical, not recommended): Sigmoidopexy (fixation to abdominal wall) - high recurrence; mesosigmoidoplasty

---

• Resuscitate: IV fluids, IV antibiotics, urinary catheter
• Emergency laparotomy:
  • Assess viability of sigmoid colon
  • If viable: Decompression + resection + primary anastomosis (safer if no contamination, low risk patient)
  • If gangrenous/perforated: Hartmann's procedure (sigmoid resection + end colostomy + rectal stump closure) - safest option in contaminated field; avoids anastomosis under unfavorable conditions; colostomy reversal 3-6 months later
  • Avoid on-table anastomosis in grossly contaminated, ischaemic bowel

• Right hemicolectomy is treatment of choice (caecal fixation has high recurrence)

---

Q3. Intussusception - Management + Recent Advances ⭐⭐⭐⭐

Definition

Age Groups and Lead Points

• Idiopathic (95%): No pathological lead point; enlarged Peyer's patches (post-viral) act as physiological lead point
• Type: Ileocolic (most common), ileocaecal

• Always has a pathological lead point (polyp, carcinoma, Meckel's diverticulum, lymphoma, GIST, submucosal lipoma)
• Ileocolic, colocolonic

Clinical Features (Infants)

• Classic triad (complete in only 20-30%):
  1. Colicky, intermittent abdominal pain (child draws up legs, screams, then settles)
  2. "Red-currant jelly stool" (blood + mucus - late sign indicating mucosal necrosis)
  3. Sausage-shaped mass in RUQ (Dance's sign - empty RIF)
• Vomiting (early, non-bilious → bilious)
• Lethargy, pallor (ischaemia)
• Distension (late)

Investigations

• Ultrasound abdomen - investigation of choice:
  • "Target sign" (transverse) / "Pseudokidney sign" (longitudinal): Concentric rings of bowel
  • Near 98% sensitivity and specificity
  • Can show free fluid, vascularity of lead point
• AXR: Soft tissue mass in RUQ; paucity of gas in RIF; small bowel obstruction pattern
• Contrast enema (Air or Barium): Diagnostic + therapeutic; "Coiled spring sign" on barium; "Meniscus sign" on air

Management

Non-operative Reduction (First-line in infants without peritonism):

• Air insufflated under fluoroscopy/USS guidance via rectal catheter
• Maximum pressure: 120 mmHg in infants
• Endpoint: Free reflux of air into terminal ileum confirms reduction
• Success rate: 60-90%
• Contraindications: Peritonitis, perforation, prolonged (>48 hrs) intussusception, shocked patient

• Barium now largely replaced by saline or Gastrografin
• Success rate: 50-75%
• Advantage of USS-guided saline: No radiation

• Duration <48 hours; no peritonism; no perforation; haemodynamically stable

Operative Reduction (Indications):

• Failed non-operative reduction
• Peritonitis, perforation
• Adult intussusception (always surgical - pathological lead point)
• Prolonged history

• Manual reduction (squeezing from below distally) - gentle milking; do NOT pull
• If bowel not viable or cannot reduce: Resection + primary anastomosis (right hemicolectomy if ileocolic)
• Adults: Resection first (without prior reduction - risk of releasing viable tumor or seeding cancer cells)

1. Ultrasound-guided hydrostatic reduction (no radiation)
2. Laparoscopic reduction (for older children and adults with small bowel-small bowel intussusception)
3. Improved Air enema technique with real-time fluoroscopy monitoring
4. Reducing recurrence after pneumatic reduction: 2-3% recurrence - can reattempt non-operative if recurs once; surgery after 2nd recurrence

---

Q1. Colonoscopy - Indications, Technique & Complications ⭐⭐⭐⭐

Definition

Indications

1. Lower GI bleeding (PR bleeding, melena with negative OGD)
2. Rectal bleeding investigation (exclude carcinoma)
3. Change in bowel habit (>6 weeks in adults >40 years)
4. Unexplained iron deficiency anaemia
5. Colorectal cancer screening (≥50 years; or younger with family history)
6. Surveillance after polypectomy
7. Surveillance in long-standing UC/Crohn's (≥8-10 years pancolitis)
8. Abnormal imaging (CT findings requiring tissue)
9. Diarrhea - biopsy for IBD, microscopic colitis
10. Evaluation of submucosal lesion (GIST, lipoma)

1. Polypectomy (electrosurgical snare, EMR, ESD)
2. Haemostasis (bleeding diverticulum, angiodysplasia - injection, clips, APC)
3. Sigmoid volvulus: Decompression/detorsion
4. Stricture dilatation (balloon) or stent insertion (malignant LBO)
5. Foreign body removal
6. Tattooing of lesion for surgical identification
7. Ablation of angiodysplasia (APC - argon plasma coagulation)

• Recent MI (<6 weeks)
• Acute peritonitis/perforation (absolute)
• Toxic megacolon (relative - increased perforation risk)
• Inadequate bowel prep (relative)
• Coagulopathy (INR >2.5 for therapeutic; diagnostic acceptable if corrected)

Bowel Preparation

• Low-residue diet 24-48 hrs prior
• Polyethylene glycol (PEG) solution (4L) or split-dose regimen
• Sodium picosulphate + magnesium citrate (Picolax)
• Clear fluids only on the day
• Anti-propulsive agents avoided (delay transit)

Technique

1. Sedation: IV midazolam + fentanyl (conscious sedation) or propofol
2. Left lateral or prone position
3. Digital rectal examination first
4. Lubricated scope introduced; advance under direct vision with air/CO2 insufflation
5. Torque steering technique; loop reduction manoeuvres
6. Advance to caecum: Identify appendix orifice + ileocaecal valve (confirms complete)
7. Intubate terminal ileum (assess for Crohn's, lymphoma)
8. Systematic withdrawal with mucosal inspection, air aspiration
9. Photo document: Caecum, hepatic flexure, splenic flexure, rectum, any lesion
10. Therapeutic procedures performed during withdrawal

Complications (Exam Favourite!)

1. Perforation (most serious): 0.03-0.1% diagnostic; 0.1-0.3% after polypectomy
   • Site: Sigmoid colon (commonest - sharp angulation)
   • Signs: Sudden abdominal pain + distension + free gas on AXR/CT
   • Management: Small/contained without peritonism → IV antibiotics + observation; larger → laparoscopy/laparotomy + repair; Hartmann's if soiled
2. Haemorrhage: 0.3-1.0% after polypectomy; 0.01% diagnostic
   • Usually within 2 weeks (delayed post-polypectomy bleed)
   • Management: Endoscopic hemostasis (injection, clips); rarely surgery
3. Cardiorespiratory events: Related to sedation (O2 desaturation, hypotension, arrhythmia)
4. Bacteraemia/sepsis: Rare; antibiotic prophylaxis for high-risk cardiac patients
5. Post-polypectomy syndrome: Transmural burn → local peritonitis without perforation; fever + pain; managed conservatively

• Anastomotic stricture after polypectomy EMR/ESD
• Missed lesion (flat adenomas, right colon)

---

Q4 & Q(1-bottom). Pathology of Inflammatory Diseases of the Bowel ⭐⭐⭐⭐⭐

Comparison: UC vs. Crohn's Disease

---

Diverticular Disease of the Colon

• False/pulsion diverticula: Mucosa + submucosa herniate through muscular wall at sites of weakness where vasa recta penetrate
• Location: Sigmoid colon (most common); right-sided (common in Asia)
• Acquired; associated with low-residue diet, raised intraluminal pressure, ageing

1. Diverticulitis: Perforation of diverticulum → local inflammation; pericolic abscess; generalized peritonitis
2. Haemorrhage: Erosion of vasa recta → painless, profuse haemorrhage (most common cause of massive LGI bleed in elderly)
3. Obstruction: Inflammatory stricture
4. Fistula: Colovesical (most common - pneumaturia, fecaluria), colovaginal, colocutaneous

• Sigmoid resection + end colostomy + rectal stump closure
• Reversal 3-6 months later

---

Q5. Hirschsprung's Disease ⭐⭐⭐⭐

• Absent ganglion cells in Auerbach's + Meissner's plexuses (neural crest migration failure)
• Always starts at IAS and extends proximally
• Diagnosis: Suction rectal biopsy (gold standard) - absent ganglion cells + acetylcholinesterase positive hypertrophied nerves
• Definitive: Pull-through procedures (Swenson, Duhamel, Soave) - laparoscopic preferred
• Complication of surgery: Hirschsprung-associated enterocolitis (HAEC): Post-pull-through diarrhea, fever, distension → treat with anal wash-outs, antibiotics

---

Q6 & Q12 (2019). Various Laparoscopic Colonic Procedures & Complications ⭐⭐⭐⭐⭐

Laparoscopic Colonic Surgery: General Principles

• Reduced postoperative pain
• Earlier return of bowel function
• Shorter hospital stay (3-4 days vs 7-10 days)
• Reduced wound infection, incisional hernia
• Earlier return to work and normal activity
• Equivalent or improved oncologic outcomes (CLASSIC, COLOR, COST trials)

• Colorectal cancer (most common)
• Diverticular disease
• IBD (UC - colectomy; Crohn's - resection)
• Hartmann's reversal
• Volvulus (elective sigmoid colectomy)
• Endoscopic polypectomy rescue

---

A. Laparoscopic Right Hemicolectomy

• Supraumbilical or infraumbilical 12mm camera port (Hassan)
• Right iliac fossa 5mm
• Suprapubic 12mm (main working)
• Left lateral 5mm
• +/- Right upper quadrant 5mm

1. Exploration; Trendelenburg + left tilt (bowel falls medially)
2. Medial-to-lateral approach (preferred):
   • Identify ileocolic pedicle at its origin from SMA
   • Score the peritoneum medially; develop the retroperitoneal plane
   • Divide ileocolic vessels close to SMA (D3 dissection for oncology)
   • Lift mesocolon off the retroperitoneum (protecting ureter, duodenum, gonadal vessels)
   • Divide right colic vessels (if present) + hepatocolic ligament
3. Lateral-to-medial (alternative):
   • Divide white line of Toldt laterally; mobilize colon medially
4. Hepatic flexure mobilization: Divide hepatocolic ligament + greater omentum from transverse colon
5. Extraction: Small incision (usually periumbilical or Pfannenstiel) - extend one port; extract bowel in bag
6. Extracorporeal anastomosis: Divide terminal ileum (15-20 cm from ICV) + transverse colon; side-to-side stapled ileotransverse anastomosis; close enterotomies with linear stapler or suture
7. Intracorporeal anastomosis (advanced): Functional end-to-end anastomosis completed entirely inside; smaller extraction incision

• Right ureter (crosses iliac vessels)
• Duodenum (D2 retroperitoneal - behind right colonic mesentery)
• SMV/SMA
• Gonadal vessels
• Common iliac vessels

---

B. Laparoscopic Left Hemicolectomy / Sigmoid Colectomy

1. Identify inferior mesenteric artery (IMA) at its origin from aorta; divide with clips/LigaSure (high ligation for oncology)
2. Mobilize sigmoid + descending colon medial-to-lateral (retroperitoneal plane)
3. Identify left ureter (crosses at the level of IMA division - must protect)
4. Divide sigmoid mesentery; mobilize splenic flexure if needed
5. Divide bowel with linear endoscopic stapler
6. Extract specimen
7. Colorectal anastomosis with circular stapler (EEA) - double-stapling technique

---

C. Laparoscopic Total/Subtotal Colectomy (for UC/FAP)

• All segments mobilized; rectum divided at appropriate level
• IPAA (J-pouch) formed; or end ileostomy
• Requires full colorectal expertise

---

Specific Laparoscopic Procedures

• Ports: Umbilical (camera) + suprapubic + RIF
• Identify base of appendix; Clip/Endoloop mesoappendix; divide appendicular artery; clip base + divide; specimen in bag; lavage if perforated

• Laparoscopic abdominal phase: Rectal mobilization (TME plane); end sigmoid colostomy
• Perineal phase: ELAPE (extralevator) - division of levators at origin for adequate margin
• Specimen extracted through perineum

---

Complications of Laparoscopic Colonic Surgery

1. Veress needle/trocar injury: Bowel, vessel, bladder
2. Port site hernia (10mm+ ports)
3. Port site metastasis (cancer cases)
4. Subcutaneous emphysema

---

Q7. Carcinoma of Right Colon and Rectum ⭐⭐⭐⭐⭐

Carcinoma of Right Colon

• Occult blood loss → iron deficiency anaemia (fatigue, lethargy, dyspnoea)
• Right iliac fossa mass (palpable in 50% at diagnosis)
• Weight loss, anorexia
• Diarrhea (secretory - large tumour secreting mucus)
• Rarely: Perforation presenting as RIF pain (mimics appendicitis)

• Right hemicolectomy with D2 (high) lymph node dissection:
  • High ligation of ileocolic + right colic + right branch of middle colic arteries at their SMA/MCA origins
  • Removal of at least 12 lymph nodes for adequate staging (AJCC recommendation)
  • Reconstruction: Ileotransverse anastomosis (side-to-side stapled or end-to-end sutured)
• Laparoscopic approach increasingly standard (CLASSIC, COLOR, COST trials confirm non-inferiority to open)
• Extended right hemicolectomy: If hepatic flexure or proximal transverse colon involved

• Stage III (node positive) + high-risk Stage II: CAPOX (capecitabine + oxaliplatin) or FOLFOX 6 months
• Stage II with mismatch repair deficiency (MSI-high): Generally does NOT benefit from 5-FU (may be detrimental)

---

Q8. Ileoananal Pouch Procedure (IPAA - Restorative Proctocolectomy) ⭐⭐⭐⭐

Indications

1. Ulcerative colitis (definitive curative surgery - most common indication)
2. Familial adenomatous polyposis (FAP) - prophylactic; prevents colorectal cancer
3. Selected cases of Crohn's colitis (controversial; higher complication/failure rate)

Contraindications

• Crohn's disease with small bowel involvement (high pouch failure rate)
• Low resting anal pressure / faecal incontinence (pouch will not function)
• Low rectal cancer (need irradiated field)
• Patient's preference for stoma over frequent stools
• Old age/poor sphincter function

Pouch Configurations

1. J-pouch (most common, 90%): Two 15-cm limbs of terminal ileum folded into J-shape; side-to-side anastomosis with linear stapler; creates 30-cm reservoir; simple construction
2. S-pouch: Three 10-cm limbs sutured together; larger reservoir; needs nipple valve; risk of evacuation difficulty
3. W-pouch: Four 8-cm limbs; largest reservoir; technically demanding; rarely used

Operative Steps (Standard Three-Stage Approach for Acute/Severe UC)

• Emergency/acute setting (toxic megacolon, severe acute UC)
• Remove colon; leave rectal stump
• Allows patient to recover, stop steroids

• Remove rectum (mucosectomy or double-stapling technique)
• Construct J-pouch from terminal 30 cm of ileum
• Pouch-anal anastomosis:
  • Double-stapling technique (most common): Staple rectal stump at dentate line; circular stapler (EEA 29-31 mm) fires through anus to create end-to-end pouch-anal anastomosis
  • Mucosectomy + handsewn anastomosis: Manual mucosectomy of retained rectal mucosa + sutured anastomosis at dentate line; ensures no residual rectal mucosa at risk of cancer (theoretical advantage)
• Loop ileostomy (proximal to pouch): Protects anastomosis; reduces consequences of leak

• After confirming pouch integrity with Gastrografin enema
• Simple ileostomy closure with hand-sewn or stapled anastomosis

Complications of IPAA

1. Anastomotic leak (5-15%): Most serious; pelvic sepsis; may require pouch defunctioning/excision
2. Small bowel obstruction
3. Haemorrhage

1. Pouchitis (most common late complication - 30-50%): Non-specific inflammation of pouch; urgent/frequent stools, blood; diagnosed by pouchoscopy + biopsy; treat with metronidazole/ciprofloxacin; chronic pouchitis → anti-TNF therapy
2. Anastomotic stricture: Dilation under GA
3. Pouch-vaginal fistula: Difficult; often requires pouch advancement/re-do anastomosis; if Crohn's → may need pouch excision
4. Small bowel obstruction (adhesions)
5. Sexual dysfunction (autonomic nerve injury during pelvic dissection)
6. Bladder dysfunction
7. Pouch failure (~5-10%): Excision + permanent ileostomy

• Mean stool frequency: 4-8/day
• Patient satisfaction: ~85-90%
• Nocturnal incontinence: 10-20%

---

Q9. Primary Peritonitis (10°) ⭐⭐⭐

Definition

Types

• In patients with cirrhosis + ascites (most common - 10-30% of cirrhotics)
• Mechanism: Bacterial translocation from gut → ascites; impaired peritoneal defenses; low ascitic complement
• Organisms: Gram-negative enteric (E. coli, Klebsiella) in 70%; S. pneumoniae
• Diagnosis: Ascitic tap: Neutrophil count >250 cells/mm³ (diagnostic); Culture: Single organism
• Treatment: IV cefotaxime (3rd generation cephalosporin) 2g TDS for 5 days; IV albumin (1.5 g/kg day 1 + 1 g/kg day 3) - reduces hepatorenal syndrome risk
• Prophylaxis: Norfloxacin 400 mg/day (long-term) for secondary prevention

• Streptococcal peritonitis (girls; S. pneumoniae ascending from vagina)
• Diagnosis of exclusion (must rule out appendicitis/perforation)
• Treatment: IV penicillin/cephalosporin; laparoscopy if diagnosis uncertain

• In renal patients on peritoneal dialysis
• Organisms: Coagulase-negative Staphylococcus (most common), Staph. aureus
• Cloudy dialysate + peritoneal signs
• Treatment: Intraperitoneal antibiotics (vancomycin + gentamicin) through catheter; remove catheter if recurrent or fungal

---

Q10 & Q6. Laparoscopic Hemicolectomy & Complications (20 marks) ⭐⭐⭐⭐⭐

• Incidence: Colorectal anastomosis 2-7%; ileocolic 1-2%
• Risk factors: Distal anastomosis (lower rectal), tension, ischaemia, contamination, steroid use, malnutrition, obesity, male sex, neoadjuvant radiation

• Day 3-7 postoperatively (earlier if major leak)
• Fever, tachycardia, abdominal pain, peritonism
• Purulent/faecal discharge from drain or wound

• CRP >150 mg/L on day 3 post-op is highly predictive of leak
• CT abdomen with rectal contrast (water-soluble): Free gas, collection, anastomotic defect

• Small/contained (no peritonism): IV antibiotics + CT-guided drainage + defunctioning stoma (if not already defunctioned)
• Large/peritonitis: Return to theatre: Wash out + Hartmann's (safest) or refashion anastomosis + proximal stoma
• Defunctioning loop ileostomy early (before leak becomes established): Reduces downstream contamination

---

Q11 (2017). Familial Adenomatous Polyposis (FAP) ⭐⭐⭐⭐

Definition and Genetics

• Autosomal dominant inherited condition
• Mutation of the APC gene (Adenomatous Polyposis Coli) on chromosome 5q21
• Characterized by development of hundreds to thousands of colorectal adenomas (>100 is diagnostic)
• If untreated: 100% lifetime risk of colorectal cancer (usually by age 40-50)

Attenuated FAP (AFAP)

• Fewer polyps (10-99); later cancer risk; mutations at proximal or distal end of APC gene

Clinical Features

• Polyps develop from puberty (10-12 years); cancer develops ~20-25 years later
• Rectal bleeding, diarrhea, mucus per rectum
• Diagnosis: Colonoscopy (carpet of polyps from caecum to rectum)

1. Desmoid tumours (15-20%): Fibrous tumors; most common in mesentery/abdominal wall; locally aggressive but non-metastasising; worst complication of FAP surgery; treated with NSAIDs (sulindac), anti-oestrogens (tamoxifen), imatinib, radiation
2. Duodenal/Periampullary polyps/cancer (Spigelman staging I-IV): 2nd most common cancer cause of death in FAP; surveillance duodenoscopy mandatory; ampullary cancer - Whipple's procedure
3. Gastric fundic gland polyps (80-90%): Usually benign
4. Osteomas (skull, jaw): Benign; Gardner's feature
5. Epidermoid cysts (skin)
6. Congenital Hypertrophy of Retinal Pigment Epithelium (CHRPE): Pigmented retinal lesion; early marker of FAP; ophthalmoscopic examination in family screening
7. Thyroid cancer (papillary)
8. Hepatoblastoma (children)

Diagnosis and Screening

• Family history + colonoscopy: All first-degree relatives of FAP patients should be screened from age 10-12
• Genetic testing (APC mutation analysis): Offered to all family members; positive = colonoscopic surveillance; negative = general population risk
• Colonoscopy: Classic finding of >100 adenomatous polyps (sessile + pedunculated, throughout colon)

Management

• Removes all colorectal mucosa
• Eliminates cancer risk
• J-pouch provides reservoir function
• Requires surveillance pouchoscopy (pouch adenomas develop in ~30%)

• Colon removed; rectum retained + anastomosed to ileum
• Advantage: Fewer functional problems (less diarrhea, better continence, no pouch complications)
• Disadvantage: Retained rectum still at cancer risk (25-30% develop rectal cancer by age 50); lifelong surveillance sigmoidoscopy (every 6 months); only suitable if <5 rectal polyps at diagnosis
• Not recommended if >5 rectal polyps or high AFAP-mutation risk

• If IPAA contraindicated (incontinence, low rectal cancer in FAP)

• Surgery recommended in late teenage years (before 25, ideally 16-20 years) when polyp burden is high but before cancer develops

• NSAIDs (Sulindac, Celecoxib): Reduce polyp burden; do NOT replace surgery; useful for upper GI polyps and desmoids
• Surveillance post-surgery: Pouchoscopy + duodenoscopy (Spigelman protocol)

---

Q13 (2016). Staplers in GI Surgery (20 marks) ⭐⭐⭐⭐⭐

Introduction and Principles

Types of Staplers

1. Linear Stapler (GIA - Gastrointestinal Anastomosis Stapler / TA - Thoracoabdominal)

• Fires two double rows of staples simultaneously AND divides the tissue between them
• Available in various lengths: 60 mm, 80 mm, 100 mm
• Cartridge colours by tissue thickness:
  • White (2.5 mm): Vascular (thin tissue, vessels)
  • Blue (3.5 mm): Standard bowel, small bowel, stomach
  • Green (4.1 mm): Thick tissue, stomach (thicker wall)
  • Purple (4.8 mm): Very thick tissue
• Laparoscopic version: Endoscopic GIA (Endo-GIA or SGIA)

• Fires two rows of staples but does NOT divide tissue
• Bowel transection then divided with knife/scissors by surgeon
• Used for: Bowel closure before resection, rectal stump closure in Hartmann's

2. Circular (EEA) Stapler - End-to-End Anastomosis Stapler

• Creates circular anastomosis by firing two concentric rows of staples + cutting a doughnut of tissue centrally
• Sizes: 21, 25, 28, 29, 31, 33 mm (diameter) - choose based on bowel lumen
• Uses:
  • Colorectal anastomosis (most common use in UK)
  • Oesophagogastric anastomosis
  • Ileoanal pouch anastomosis
  • Low anterior resection
  • Esophagojejunostomy (after oesophagectomy/total gastrectomy)
• Technique for colorectal anastomosis:
  • Rectal stump closed with TA stapler (first staple line)
  • EEA stapler introduced through anus; spike advanced through posterior rectal stump or through closed stump
  • Anvil (placed on proximal bowel end and secured with purse-string suture) attached to spike
  • Stapler approximated + fired → "double stapling technique"
  • Check: Two "doughnuts" (tissue rings) must be complete and intact - confirms full anastomosis

3. Linear Cutter (Intraluminal Anastomosis Stapler)

• Used for side-to-side anastomoses (functional end-to-end)
• Ileocolic anastomosis; ileotransverse anastomosis

4. Laparoscopic Staplers

• Articulating linear staplers for laparoscopic use
• Endo-GIA with roticulating head for angled firing in pelvis
• Essential for laparoscopic rectal surgery, low anterior resection, gastrectomy

---

Applications of Staplers in Specific GI Operations

---

Advantages of Staplers Over Hand-Sewn Anastomosis

---

Complications of Stapled Anastomoses

1. Anastomotic leak (incomplete donuts, ischaemia, tension)
2. Anastomotic stricture (especially EEA - circular scar; treat with balloon dilatation)
3. Incomplete staple line / misfire (always check donuts + test air leak under water)
4. Bleeding from staple line (haemostatic sutures may be needed)
5. Dog-ear formation (at ends of linear staple line)
6. Staple line dehiscence (poor tissue, infection)

---

Q2 (bottom). Principles of Anastomosis of Intestines + Use of Staplers ⭐⭐⭐⭐⭐

Prerequisites for a Successful Anastomosis (Halsted's Principles + Modern)

• Adequate blood supply (most important - ischaemia → leak)
• Vascularized healthy tissue ends (no tension, no ischaemia)
• Absence of distal obstruction
• Suture/staple line must be tension-free
• Technique: Mucosa-to-mucosa apposition; watertight

• Good surgical technique: Atraumatic handling; meticulous haemostasis
• Nutritional status: Albumin >30 g/L optimal
• Avoid anastomosis in contaminated field (Hartmann's preferred)
• Avoid anastomosis under radiation field

Types of Intestinal Anastomosis

1. End-to-end: Direct; preserves bowel length; risk of size mismatch; tension
2. End-to-side: Useful when size mismatch; biliary-enteric (HJ)
3. Side-to-side: Widest anastomosis; least tension; preferred for isoperistaltic bowel

1. Single-layer interrupted: Gold standard - less ischaemia, technically demanding; PDS/Vicryl
2. Two-layer: Inner continuous absorbable + outer interrupted non-absorbable (Lembert sutures); traditional; more blood supply compromise
3. Stapled: See Q13

1. Hand-sewn (sutured)
2. Stapled - see Q13

Suture Materials for Anastomosis

• Absorbable: PDS (polydioxanone) - monofilament; slow absorption (90-180 days); preferred for most GI anastomoses; Vicryl (polyglactin) - braided; absorbed 60-90 days
• Non-absorbable: Prolene (polypropylene) - for vascular/biliary; Nylon

Techniques of Intestinal Anastomosis

1. Prepare bowel ends: Trim fat, ensure healthy viable tissue
2. Posterior row (from inside): Full-thickness interrupted sutures 3 mm apart, 3 mm from edge; absorbable 3/0 PDS
3. Anterior row: Same sutures; close lumen completely
4. Test: Gently squeeze and check for leaks; mesenteric gap closed

1. Divide bowel with GIA stapler (both ends closed)
2. Align anti-mesenteric borders; create small enterotomies at tips
3. Fire GIA into each limb (creates side-to-side anastomosis)
4. Close enterotomies with TA stapler or hand-sewn

Factors Predisposing to Anastomotic Leak

• Distal colonic/rectal anastomosis (low AP)
• Inadequate blood supply (ischaemia, tension)
• Contaminated field
• Malnutrition (low albumin)
• Steroids, immunosuppression
• Radiation
• Distal obstruction
• Previous surgery (scarring)
• Emergency surgery